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Bioactive glasses are a promising, relatively new material group to be utilized in regen-
erative medicine. The main target area of these materials is in bone tissue engineering, 
where commercial products are already used; in the form of as granules and pastes. In 
future, there is an ever increasing demand for artificial bone grafts having 3-D structure 
and high mechanical strength. 
Traditional bioactive glasses are silica-based. Despite their known biological properties, 
they tend to crystallize easily upon heat processing. In clinical studies it has been found 
that they do not completely convert to hydroxyapatite (HA); the substance which is re-
placeable by bones’ remodeling mechanism. Boron containing glasses may overcome 
these problems as they convert faster to HA and have enhanced thermal properties. The 
objective of the study was to assess if magnesium and strontium could further improve 
the properties of a borosilicate glass composition. In the study, part of the calcium was 
substituted with magnesium and/or strontium and the impact on (i) sintering and (ii) dis-
solution of the produced glasses studied. 
Six different glass compositions were prepared. A borosilicate glass with composition 
47.1 SiO2 - 6.7 B2O3 - 22.7 Na2O - 21.8 CaO - 1.7 P2O5 in mol-% (labelled B12.5) was pre-
pared and used as reference. This glass composition corresponds to the current commer-
cial silicate bioactive glass, S53P4, where 12.5% of the SiO2 is replaced with B2O3. From 
this composition, glasses with different amounts of Mg and/or Sr were produced. The 
change in physical, structural and thermal properties, induced by the substitution, were 
studied. Sintering and crystallization was studied at various temperatures and analyzed 
with scanning electron microscopy (SEM) and X-ray diffraction (XRD). The bioactivity 
of the glasses was assessed by dissolution in simulated body fluid (SBF), for immersion 
time from 6 hours to 2 weeks. Upon dissolution the pH of the solution and the amount of 
ions leached out from the glass to the SBF was measured. Fourier transform infrared 
(FTIR) spectroscopy was utilized to evaluate HA formation on the glass surface.  
Results showed that Mg and Sr assume similar structural role, in the glass network, as 
calcium. Mg and Sr seemed to improve the overall sintering behavior by decreasing the 
glass viscosity. Ions released from the glasses upon immersion decreased with increasing 
Ca substitution. The formation of HA layer appeared quite rapidly on all of the glasses. 
Mg and Sr are suspected to be introduced in the HA layer formed at the surface of the 
glass. The mixed glass (containing both Mg and Sr) seem to be the best candidate for 
future work on glass scaffold sintering for tissue engineering. 
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Bioaktiiviset lasit ovat lupaava, suhteellisen uusi materiaaliryhmä, joista valmistettuja 
tuotteita hyödynnetään kudosteknologian sovelluksissa. Kyseisten materiaalien eräs 
tärkeimmistä käyttökohteista on rekonstruktiivinen kirurgia, jossa kaupallisia tuotteita 
hyödynnetään luunsiirteiden korvikkeina, esimerkiksi lasirakeiden ja kittien muodossa. 
Keinotekoisten, luuta korvaavien sovellusten kysyntä onkin jatkuvassa kasvussa. 
Perinteiset bioaktiiviset lasit ovat tyypillisesti piidioksidipohjaisia. Vaikkakin näillä 
materiaaleilla on useita erinomaisia ominaisuuksia, kuumennusta vaativat käsittelyt 
saavat niissä aikaan epätoivottua kiteytymistä. Kliinisissä tutkimuksissa on myös havaittu 
että implantoidut materiaalit eivät ole muuntuneet täysin hydroksiapatiitiksi (HA); 
yhdisteeksi, jonka luun solut pystyvät korvaamaan regeneroituvalla kudoksella. 
Booripitoiset lasit ovat monilta ominaisuuksiltaan nykyisiä kaupallisia koostumuksia 
lupaavampia. Työn tavoitteena oli tutkia, parantuvatko borosilikaattilasin ominaisuudet 
kun lasin koostumukseen lisätään magnesiumia tai strontiumia. Tutkimuksen perustana 
käytetty borosilikaattilasi B12,5 (47,1 SiO2 - 6,7 B2O3 - 22,7 Na2O - 21,8 CaO - 1,7 P2O5, 
mol-%) valmistettiin kaupallisen piidioksidilasin S53P4 koostumusta muuntaen. Osa 
borosilikaattilasin sisältämästä kalsiumista korvattiin vaihtelevilla magnesium ja/tai 
strontium pitoisuuksilla. Tämän vaikutusta valmistettujen lasien sintrautuvuuteen ja 
liukenemiseen arvioitiin tarkastelemalla muutoksia lasien fyysisissä, rakenne- sekä 
lämpöominaisuuksissa. Työssä tutkittiin yhteensä kuutta eri lasikoostumusta. 
Valmistettuen lasien sintrautumista tarkasteltiin useassa lämpötilassa, ja näytteitä 
analysoitiin pyyhkäisyelektronimikroskopialla (SEM) sekä röntgendiffraktiolla (XRD). 
Lasien bioaktiivisuutta tutkittiin liottamalla laseja fysiologisia nesteitä simuloivassa SBF-
liuoksessa. Näytteiden immersioaika vaihteli kuudesta tunnista kahteen viikkoon.  
Jokaisen aikapisteen jälkeen immersioliuosten pH mitattiin, sekä liuoksen ionipitoisuus 
määritettiin induktiivisesti kytketyllä plasma-atomiemissiospektrometrialla (ICP-AES). 
FTIR-spektroskopiaa käytettiin arvioimaan HA:n muodostumista lasien pinnalle.  
Työssä havaittiin magnesiumin ja strontiumin ottaneen lasien rakenteessa kalsiumia 
vastaava rooli. Yleisesti ottaen, magnesium ja strontium vaikuttivat parantavan lasien 
yleistä sintrautuvuutta laskemalla lasien viskositeettiä. Tämän lisäksi, kaikkien tutkittujen 
lasien pinnalle muodostui bioaktiivisuutta indikoiva HA kerros. Lasien liukenevuus laski 
kun kalsiumpitoisuutta korvattiin kasvavissa määrin. Lasikoostumuksessa, jossa esiintyi 
sekä magnesiumia että strontiumia, yhdistyi kummankin elementin suotuisat vaikutukset. 
Tämä koostumus vaikutti lupaavimmalta luukudosteknologian sovelluksiin. 
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1. INTRODUCTION 
Currently, regenerative medicine still utilizes tissue grafts as the golden standard in re-
construction of bone defects. Tissue grafts have many limitations, where the availability 
is one of the most substantial. Although major progresses in field of bone tissue engineer-
ing have been achieved during the years, no adequate bone substitute have yet been de-
veloped. (Amini et al. 2012; Salgado et al. 2004). 
Tissue engineering is an interdisciplinary field utilized in regenerative medicine. The 
main target of tissue engineering is to restore or improve functionality to damaged or 
diseased tissues. This usually approached by use of implantable temporary structures, re-
ferred as scaffolds. Scaffolds are structural matrixes used to support the regenerative tis-
sue. Therefore, it is understandable that the scaffolds need to fulfill many requirements 
considering both biological and mechanical aspects. For example in field of bone tissue 
engineering, these include biocompatibility, structural properties such as porosity and 
surface properties, osteostimulative properties, adequate mechanical properties and bio-
degradability. Most of the essential properties are attributed to the material from which 
the device is manufactured. (Langer & Vacanti 1993; Salgado et al. 2004). 
Bioactive glasses are a relatively young material group, which are categorized under bio-
ceramic materials. In general, a material is considered bioactive when it can evoke a spe-
cific biological response at the materials interface, resulting in the formation of a bond 
between the surrounding tissues and the material. Bioactivity of a glass is a result of the 
materials composition and its amorphous open network that enables reactions with phys-
iological fluids. The leaching of ions from the glass leads to reaction whereas a hydroxy-
apatite (HA) layer forms at the glasses surface. The formed HA is similar to the mineral 
phase of bone, providing an optimum substrate for cells to attach, proliferate and differ-
entiate. Bioactive glasses have, in fact, been among the first synthetic materials shown to 
form a rapid bonding to bone tissue. (Brauer 2015; Hench & Jones 2015). 
Although bioactive glasses have been in clinical use for over thirty years, the commercial 
applications are still restricted to products such as glass granules and pastes (Jones 2013). 
Even though the current bioactive glasses on the market hold many desirable properties, 
they however have been found, for example, to have a strong tendency to undergo crys-
tallization when exposed to heat processing. This limits the possible products obtainable 
via hot forming. Since the bioactivity of the bioactive glasses is linked to their amorphous 
structure, crystallization is problematic as it makes the glass network more stable, thus 
less reactive. (Arstila et al. 2008; Bellucci et al. 2010; Groh et al. 2014; Massera et al. 
2012a) In addition, in clinical studies remnants of implanted bioactive glass granules can 
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be found even after 14 years post operation. This indicates that degradation of the material 
has be restricted, and hence the granules could not been entirely replaced by the regener-
ating tissue. (Lindfors et al. 2010). 
Many of the challenges can be linked to the silica-based composition of the commercial 
glasses. The low silica content along with high alkali and alkaline earth ions in the glass 
structure leads to a highly disordered and open network that is prone to crystallization. 
(Arstila et al. 2008; Massera et al. 2012a). Fortunately, glass properties can be improved 
by making slight alteration to their compositions. For example, introduction of alkali earth 
such as magnesium can enhance e.g. the thermal properties of a bioactive glass. (Brink 
1997). Borate glasses possess wider hot forming domain and slower crystallization kinet-
ics than bioactive silicate glasses. Therefore, borosilicate glasses containing ions such as 
Mg can have favourable properties for the processing of scaffolds. In addition, unlike 
silica-based glasses, borate glasses have higher degradation rate and they have been found 
to completely convert into HA-like material. Their degradation rate is also adjustable, and 
can be matched with the regeneration of the tissue. (Huang et al. 2006; Rahaman et al. 
2011). 
During this study, the composition of a borosilicate glass was modified by substituting 
some of the calcium content with magnesium and/or strontium. The addition of Mg was 
expected to affect to the thermal properties, giving the material a wider temperature range 
for thermal processing (Massera et al. 2012b) and Sr was utilized as it has been, for in-
stance, found to enhance the proliferation of osteoblast; therefore being beneficial for e.g. 
treatment of osteoporosis (Gentleman et al. 2010; Goel, et al. 2011). Objective of this 
thesis was to characterize some of the most essential properties of the produced borosili-
cate glasses, and assess whether the partial substitution of calcium with magnesium 
and/or strontium had an impact on (i) thermal and sintering properties of the glasses; e.g. 
to thermal processing window as well as to crystallization tendency, and (ii) assess bio-
activity of the produced glasses  based on in vitro dissolution in SBF. Initial aim was to 
assess if the investigated glass compositions would be suitable for bone tissue engineering 
applications, e.g. production of scaffolds. 
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2. TISSUE ENGINEERING OF BONE 
Bone is a very forgiving tissue. However, besides major traumas, there exist multiple 
medical situations which cause loss, failure or need for removal of bone tissue in extent 
that the tissues natural repair mechanism is impaired. Such causes include for example 
tumors and cancers, and diseases such as osteoporosis and degenerative disc disease. 
(Schoeder & Mosheiff 2011). It is worth noting that the need for regenerative medicine 
increases, as the aging population increases. As a solution to this, a field of tissue engi-
neering has emerged. The main target of tissue engineering is to restore, maintain or im-
prove functionality to damaged or diseased tissues by the means of combining cell biol-
ogy, material sciences and engineering. (Langer & Vacanti 1993; van Blitterswijk, et al. 
2008, p. 14-21). 
The use of scaffolds, devices that function as template structures and a carrier for biolog-
ically active factors, to support the normal regeneration of the tissue. Scaffolds can be 
utilized either as acellular, or as cellular systems where the matrix is embedded with cells. 
The biologically active factors can include, besides cells, molecules that stimulate the 
host tissue cells, such as growth factors. (Rahaman et al. 2011; Nguyen et al. 2012). Scaf-
folds used in tissue engineering are usually porous three dimensional (3-D) structures of 
biocompatible material that provides mechanical support and enables the regeneration of 
the compensated tissue. (van Blitterswijk et al. 2008, p. 404-405). Nowadays, it is pre-
ferred that the scaffold, as a foreign material itself inside living body, is removed from 
the body by the means of degradation and absorption. Therefore, there is need to produce 
materials which can provide the desired mechanical properties and still degrade during 
acceptable timeframe. (Hutmacher 2000). 
2.1 Biology of the bone 
Bone is a complex living tissue comprising cells and the extracellular matrix (ECM). The 
tissue develops by osteogenesis, the process of ossification, and grows by deposition of 
additional matrix on free surfaces, i.e. apposition. Bone is continually remodeled by the 
cells within it. The formation and reformation of the bone tissue is maintained mainly by 
two different cell types; the osteoblasts (‘bone-forming’) and the osteoclasts (‘bone re-
sorbing’), illustrated in Figure 1. (Alberts et al. 2008, p. 1469-1474; Ross & Pawlina 
2011, p.219, 223-232). 
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Figure 1. Schematic drawing of cells associated with bone. Modified from Ross & 
Pawlina 2011, p. 224. 
 
Osteoblasts are the cells that secrete the organic ECM of bone, which comprises mainly 
of type I collagen, in addition with noncollagenous proteins such as osteocalcin, bone 
sialoprotein and osteopontin. The secreted ECM is initially amorphous and noncrystal-
line, but gradually mineralizes due to calcium salt deposition. (van Blitterswijk et al. 
2008, p. 560). When the bone deposition ceases, the osteoblasts give rise to either osteo-
cytes or bone-lining cells. As the name suggests, the cells that remain on the surface of 
the bone in their resting state are referred as bone-lining cells. Osteocytes are type of 
osteoblasts, which have eventually been trapped and surrounded by their secreted matrix 
into spaces called lacunae. Active osteoblasts arise from the bone-lining cells, or are de-
rived from osteoprogenitor cells. Osteoprogenitor cells are, by definition, mesenchymal 
precursor cells committed to the bone lineage by differentiating into osteoblasts. The mes-
enchymal precursor or stem cells are located usually in bone marrow or other connective 
tissue. (Ross & Pawlina 2011, p. 219, 225-227).  
As new bone is constantly reformed, similarly the old needs to be removed. The resorp-
tion of the bone is conducted by osteoclasts, multi-nuclei phagocytic cells. They differ 
from their lineage compared to other bone cells, as the osteoclasts are derived from hem-
atopoietic progenitor cells. Osteoclast formation occurs from fusion of macrophage pro-
genitor cells under influence of multiple cytokines, in close association with stromal cells 
in bone marrow. (Alberts et al. 2008 p. 1457; Ross & Pawlina 2011 p. 227-232). 
Imbalance or malfunction in the normal process of remodelling can lead to several com-
plications. One of these is osteoporosis, a disease common among post-menopausal 
women. In osteoporotic bone, osteoclasts resorb too much bone while osteoblasts fail to 
create enough, resulting in disruption of the bone microarchitecture, leaving the structure 
porous and prone to fracture. (Gentleman et al. 2010). 
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2.2 Structural properties of bone tissue 
Healthy bone is a dynamic and well-organized tissue with high tensile and loading 
strength. Bone is categorized as a specialized form of connective tissue, composed with 
the mineralized ECM. The mineralization makes the tissue highly durable, and thus bones 
are capable to provide supporting system and protection to the human body (van 
Blitterswijk et al. 2008, p. 560). As mentioned, the organic component of the ECM is 
mainly formed from type I collagen. The elastic collagen fibers located within the matrix 
provide the framework for tissue structure and additionally, lead to a degree of elasticity 
within the structure. The inorganic part of the bone is comprised of calcium phosphate 
(CaP) in form of hydroxyapatite, being the component that provides the structure rigidity. 
Hence, from materials science perspective, bone can be considered as composite material. 
Bone as a tissue also serves as a storage site of, for example, calcium and therefore it has 
a secondary role in homeostatic regulation of blood calcium levels. (Ross & Pawlina 
2011, p. 218-219, 241-243; Salgado et al. 2004). 
Bones can be classified into cortical (also known as dense or compact) bone and trabec-
ular (additionally; spongy or cancellous) bone (illustrated in Figure 2). These types of 
bone differ in their structure and mechanical properties. Cortical bone has compact struc-
ture and it is located on the outside of the bones. Trabecular bone, in the other hand, can 
be found on the interior of the bone structure; it is highly porous matrix that contains for 
example hematopoietic tissue, fat tissue and blood vessels. (Nguyen et al. 2012). 
 
 
Figure 2. Bone comprises structurally from dense layer present on the outside of the bone 
(cortical bone), and a spongelike meshwork on the interior (trabecular bone). Bones are 
covered by layer of connective tissue, periosteum (indicated in pink), expect for the artic-
ular surfaces, which are covered by hyaline cartilage (indicated in blue). Modified from 
Ross & Pawlina 2011, p. 220. 
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Depending on the anatomical sites, bones exist in many different sizes and shapes. The 
structure of the bone also depends on the maturity of the tissue; mature bone is composed 
mainly of cylindrical units, which are called osteons or Haversian systems, presented in 
Figure 3a. Osteons consist of concentric lamellae that surround a central canal system 
(i.e. osteonal or Haversian canal) which enables the vascularization and nerve supply of 
the osteon. Immature bone can be found in newborn, fracture calluses or metaphyseal 
region of growing bone. The structure of immature bone is nonlamellar and the cells are 
arranged randomly within the tissue, as illustrated in Figure 3b. Immature bone is also 
referred as woven bone. (van Blitterswijk et al. 2008, p. 560-562; Ross & Pawlina 2011, 
p. 219-223). 
 
 
Figure 3. Structures of mature and immature bone. Modified from Ross & Pawlina 2011, 
p. 222-223. 
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As a result of the oriented structure, mature bone possesses anisotropic mechanical char-
acteristics. This implies that the response and tolerance of the tissue for load applications 
will be different, depending of the direction of the load in relation to bone structure ori-
entation. Bones are also viscoelastic; the behavior of the tissue differs depending on the 
speed to which the load is applied. In general, bones tolerate higher forces in the longitu-
dinal direction, as it is also the direction of the natural strain of the tissue in normal con-
ditions. This feature is due to high adaptivity of the bone tissue. The inherent architecture 
of bone is influenced by applied mechanical stresses via mechanotransduction, and hence 
e.g. rising mechanical demand from the environment may result in notable changes within 
the structure. This structure-function relationship of the bone tissue was determined and 
described as Wolff’s law already in 1892. (Bankoff 2012; Sikavitsas et al. 2001). 
2.3 Current methods of treatment 
To certain extant, bones are able to reform by themselves through the bone repair mech-
anism, and via constant remodeling. However, due to the magnitude of fracture, infection 
or other causes, in some cases reconstructive surgery is needed. Large bone defects, be-
yond the normal potential of self-healing, are usually treated with implants or transplants. 
(Amini et al. 2012; Meyer et al. 2009, p. 211-212; Salgado et al. 2004; Schoeder & 
Mosheiff 2011). 
For decades, the use of grafts has been the golden standard in tissue engineering. In graft-
ing, bone from somewhere else is applied to stimulate the formation of new bone. In fact, 
bone is one of the most transplanted tissue after blood. (Dimitriou et al. 2011). The use 
of grafts as a treatment method has however some noteworthy disadvantages. For exam-
ple, autologous grafts that are harvested from patients own locations of relative excess, 
e.g. from pelvis, prolong patients operation and healing time. Availability of the tissue is 
limited, and there is also increase of the risk of surgical complications, such as excess 
pain or infections. With allogenic and xenogenic grafts, tissue harvested from individuals 
of same or different species, respectively, lies a risk of immunogenicity problems and 
transmission of diseases. Additionally the sterilization steps and preservation of the har-
vested tissue can affect and change the material’s properties substantially. (Salgado et al. 
2004; Schoeder & Mosheiff 2011; van Blitterswijk et al. 2008, p. 563-567)  
Bone fractures and other defects will in the future increase due to ageing population. As 
the availability of graft tissue is already limited, there is therefore an ever increasing de-
mand for alternative, adequate solutions. (Langer & Vacanti 1993). 
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2.4 Stem cells in tissue engineering 
Stem cells are defined as unspecialized cells with ability to renew themselves, but also to 
differentiate in various specialized cell types. Stem cells are usually divided by their dif-
ferentiation capacity to totipotent, pluripotent, multipotent, oligopotent and unipotent 
stem cells. The most potent ones are the totipotent stem cells, which have the ability to 
form an entire organism. (van Blitterswijk et al. 2008, p. 2-3; Kolios & Moodley 2012). 
Pluripotent stem cells, such as embryonic stem cells (ESC) and induced pluripotent stem 
cells (iPSC), are under high interest in current research. While ESCs and iPS cells have 
shown nearly unlimited differential potential, the applications are still limited by ethical 
and legal concerns, as well as by issues of efficacy and safety. Because of this, as an 
alternative approach of tissue-specific multipotent stem cells circumvent many of the 
mentioned concerns. These cells can therefore be utilized in tissue engineering applica-
tions. (Gimble et al. 2007; Lindroos et al. 2011; Takahashi et al. 2007). 
Multipotency indicates the ability to form multiple cell lines. Despite multipotent stem 
cells such as the mesenchymal stem cells (MSCs) cannot differentiate in every type of 
tissue, they can be easily harvested and isolated, and additionally the cell culture is easily 
expanded. MSCs are a population of self-renewing, undifferentiated cells, which reside 
in differentiated tissues. As MSCs can be derived from adult human beings, they are eth-
ically the least controversial stem cell type. (Gimble et al. 2007; Kokai et al. 2014; Kolios 
& Moodley 2012). MSCs have ability to differentiate many different pathways towards 
multiple cell lines, including osteoblasts, adipocytes and chondroblasts, and also large 
variety of other specialized mesenchymal cell types, as for example myocytes, tendocytes 
and ligament cells. (Lindroos et al. 2011). MSCs can be harvested from easily-accessible 
tissues, such as bone marrow, fat or muscle tissue, but ultimately have been found from 
nearly every type of tissue (Romagnoli & Brandi 2014; Tsuji et al. 2014). 
As mentioned, mesenchymal stem cells have excellent osteogenic differentiation capac-
ity, as one of these cell lineages are the osteoprogenitor-derived bone cells (Ross & 
Pawlina 2011, p. 225). The differentiation may be induced via several mechanisms. One 
of the major methods is chemical stimulation e.g. with growth factors, but also the bio-
physical effects and stimulation are considered to be important regulators in bone for-
mation. It has been studied, that even the degradation byproducts from implant material 
can induce the differentiation. (Gimble et al. 2007; Hench & Jones 2015; Lindroos et al. 
2011). 
2.5 Scaffolds for bone applications 
Scaffolds are the temporary template structures used to support and promote regeneration 
of the damaged tissue. To great extent, the selected material will determine the most es-
sential properties of the scaffold. (Salgado et al. 2004). 
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2.5.1 Properties 
Several essential aspects need to be regarded when designing scaffold properties, both 
from the biological and the mechanical point of view. First, it is most important that the 
scaffold is tolerated by the host tissue. Therefore, the desired properties for scaffold ma-
terial include biocompatibility; ability to induce appropriate host response depending on 
the application, and promotion of cell adhesion and proliferation. (Hench & Wilson 2013, 
p. 1-26; Hutmacher 2000; Baino et al. 2011). Permanent implant materials are associated 
with undesirable reactions, such as infections, corrosion, fatigue and failure, which even-
tually result in implant replacement. In addition, there are concerns about stress shielding; 
a phenomena when natural load is transmitted only through the implant, and not to the 
surrounding bone. When bones are not loaded, osteoclast activity overcomes formation 
of new bone, and loss in bone volume occurs. (Hench & Jones 2015; Salgado et al. 2004). 
Nowadays, many new generation implant materials are preferred as biodegradable, i.e. 
the implanted material is gradually, and eventually wholly replaced by the regenerating 
tissue. Therefore, the degradation products that the material releases should be easily re-
sorbed or excreted by body, and additionally released by metabolically accepted rates, as 
the cells of the host tissue need to, in most cases, handle large quantities of the material. 
(Brauer et al. 2006; van Blitterswijk et al. 2008, p. 569-570 ; Hench & Wilson 2013, p.5-
9; Hupa et al. 2016). It is also beneficial that the scaffold promotes bioactivity. Bioactivity 
can be determined as materials ability to induct specific biological activity, which is usu-
ally indicated by materials ability to undergo specific surface reactions when implanted 
into the body, i.e. in vivo. The ability of a material to form a hydroxyapatite-like surface 
is often taken as an indication of bioactivity, as it has been found to promote the formation 
of new bone. (Brauer 2015; Rahaman et al. 2010).  
The structure of the implanted device needs to be porous, with interconnected porous 
network to enable the penetration of cells, tissue ingrowth, vascularization and diffusion 
of nutrients (Salgado et al. 2004; van Blitterswijk et al. 2008, p. 569). Certain pore size 
is needed to produce desirable effects; for instance, too small pores (diameter smaller than 
100 µm) can contribute the formation of fibrous tissue instead of bone. The pore size over 
300 µm has been found to be beneficial for enhancing new bone formation and formation 
of capillaries. (Karageorgiou & Kaplan 2005). However, the microporosity can be crucial 
as it results in large surface area of the material, which contributes to protein and cell 
adhesion (Vitale-Brovarone et al. 2008). 
As the bone tissue is a rigid structure under continuous stress, also the scaffolds should 
possess sufficient mechanical properties. Ideally, mechanical properties of the scaffold 
should match those of the native bone tissue, which are different for e.g. maxillofacial 
and load bearing sites. Furthermore the type, size and location of the bone cause variation 
to the requirements. For example, compressive strength, which indicates materials capac-
ity to withstand loads, for cancellous bone can range from 2 to 12 MPa, and for cortical 
bone 100-230 MPa. (Hench & Wilson 2013, p. 13; Salgado et al. 2004). Bone tissues 
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have also other characteristic properties such as tensile strength; capacity to withstand 
elongation, and elastic modules i.e. stiffness. As porosity of the material affects greatly 
to mechanical properties of a device, a compromise between mechanical properties of the 
device and density of the pores has usually to be made. (Chen et al. 2006). The mechanical 
properties of the implantable devices shouldn’t either exceed the mechanical properties 
of the host bone, as the stress shielding effect may cause further loss of the contacted bone 
(i.e. osteolysis). (van Blitterswijk et al. 2008, p. 565). 
Additionally, treatment of large segmental bone defects can be a significant challenge due 
to need of incorporation of vascular networks within engineered bone constructs. The 
processability of the scaffold material is important, as the devices are needed in anatom-
ically relevant shapes, sizes and dimensions, depending on the nature of the surrounding 
intact bone and soft tissue. (Amini et al. 2012; Hutmacher 2000; Nguyen et al. 2012). 
2.5.2 Materials 
Many different materials are utilized in bone related applications, ranging from the per-
manent metallic implants to biodegradable materials, such as bioceramics, and biode-
gradable polymers of both natural and synthetic origin. One of the new interests are com-
posite materials, which can combine the good properties of the components to overcome 
the limitations of the raw materials. (Baino et al. 2015; Liu et al. 2013; Rahaman et al. 
2000; Salgado et al. 2004). One example are the mentioned bioceramics, which despite 
being otherwise promising group of materials, are brittle and do not tolerate cyclic loads. 
The brittleness of the ceramics can be avoided by combining them with viscoelastic pol-
ymers, which by themselves suffer from poor strength. Therefore, hybrid devices pre-
pared from these type of materials have the potential to be durable with adjustable prop-
erties, such as tailored degradation rate. (Hench 1991; Jones 2013). 
Bioactive ceramics are artificial materials with ability to form a chemical bond with bone. 
According to previous studies, bioactive glasses are more efficient in formation of bond 
between the tissue and the material, and additionally more potent to stimulate the regen-
eration of the tissue than other bioactive ceramics. However, bioactive glasses still lag 
behind other bioceramics in terms of commercial success. (Hench 2006; Jones 2013).  
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3. BIOACTIVE GLASSES 
Glass is considered bioactive, when it can evoke a specific biological response at the 
materials interface, resulting in the formation of a bond between the surrounding tissues 
and the material. Bioactive glasses are a relatively young material group, which can be 
categorized under ceramics. Mainly, their interesting properties are generated by materi-
als composition and structure. Bioactive glasses have been among the first synthetic ma-
terial to be shown to form a rapid bonding to bone tissue. (Brauer 2015; Hench & Jones 
2015). 
3.1 Glass structure 
The composition of the glass determines several properties of the material. Some to men-
tion are for example the thermal properties, bioactivity and overall degradation rate. For 
the glass to be bioactive, in general, it has been noted that composition requirements are 
following; the silica content must be less than 60% (which, in comparison, is in normal 
window glass over 70%), and the composition needs to have high Na2O and CaO content 
with high CaO/P2O5 ratio. Composition of this kind makes the glasses surface reactive in 
physiological fluids. The glass’ tendency to react in aqueous solution depends on the rel-
ative proportion of bridging and non-bridging bonds in the glass network. (Hench & Jones 
2015; Rahaman et al. 2011). 
Glass is amorphous with a continuous and random network. This network is formed, in 
general, of three different components; network forming ions, network modifiers and in-
termediate oxides. This is illustrated in Figure 4.  
 
Figure 4. Illustration of bioactive glass network. The network consists of network forming 
ions, network modifiers, and intermediate oxygens. Modified from  
Hench & Wilson 2013, p. 18. 
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Network formers include components such as silica (SiO2), phosphorus pentoxide (P2O5) 
and boron trioxide (B2O3). Glass network thus in these cases forms from Si, P and B that 
are connected with bridging oxygens. Network modifiers affect the structure by forming 
ionic bonds with the bridging oxygens, turning them into non-bridging and making the 
structure more disrupted, open and, in the case of silicate glasses, more reactive. Modifi-
ers typically include alkali or alkaline-earth metals as oxides. Intermediate oxygens can 
function in both roles; as network modifiers, or possibly enter the network forming the 
backbone structure. This is the case for example of Al2O3 or ZnO. (Brauer 2015; Hench 
& Wilson 2013, p.18-19). 
3.2 Bioactivity 
Reactivity of the bioactive glasses comes from their more open network compared to the 
conventional glasses. When bioactive glasses come in contact with aqueous solutions, 
they start to dissolve and release ions to their surroundings, making them surface-active 
biomaterials. As a result of the ion release and network dissolution, the surrounding of 
the glass is saturated with Ca2+ ions. Supersaturation of the surrounding medium leads to 
the formation of an apatite surface layer. This phenomenon is often referred to as bioac-
tivity, although somewhat incorrectly as the apatite formation by itself does not prove the 
biocompatibility or functionality in in vivo conditions. (Brauer 2015; Rahaman et al. 
2011.) The hydroxycarbonated apatite (HCA) layer on the surface of the glass does how-
ever enable the ability of bioactive glasses to form a strong bond with living, primarily 
bone, tissue. HCA is similar to bone mineral and is thought to interact with collagen fibrils 
to integrate with the host bone. It has been extensively proved that with this bonding, 
bioactive glasses are able to create a stable interface that trigger a range of biological 
responses, such as tissue regeneration and angiogenesis, while the glass degrades over 
time. (Hench 2006; Jones 2013; Rahaman et al. 2011).  
It has been found that in vivo, bioactive glass stimulates more rapid bone repair than other 
bioactive ceramics. In addition, bioactive glasses possess antibacterial properties. The os-
teoinductive properties of the glass are thought to be due to the dissolution products of 
the glass, i.e. soluble silica and calcium ions that stimulate osteogenic cells to produce 
bone matrix. In in vitro studies this has been shown to cause stimulation of genes in pri-
mary human osteoblasts. (Oonishi et al. 2000; Xynos et al. 2001). Bioactive glasses can 
be further incorporated with trace quantities of other elements which are known to be 
beneficial for healthy bone growth (Hench & Jones 2015). 
Currently, there exist a standard used in in vitro evaluation for apatite-forming ability of 
implant materials. The standard specifies a method for detecting apatite formed on a sur-
face of a material in simulated body fluid (SBF). It is applicable to implant surfaces in-
tended to come into direct bone contact. (ISO 23317:2014).  The standard is intended to 
provide research laboratories around the world a protocol to allow comparison of disso-
lution rates and apatite nucleation. The standard in its current form does take into account 
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the surface area of the analyzed bioactive glass. The surface area that is in contact with 
the surrounding aqueous medium is a critical factor in reaction rate. Therefore, Macon et 
al. 2015 proposed a new unified method, where ﬁxed mass per solution volume ratio and 
agitated solution is used. This method has proved to be efficient in studying and compar-
ing samples with similar density. It should however be noted, that in vitro testing does 
not truly match conditions in vivo, as SBF does not exactly match those of the human 
body. Therefore, also in vitro cell tests need to be conducted to gain more appropriate 
estimation about the possible in vivo reactivity. (Bohner & Lemaitre 2009; Macon et al. 
2015).  
3.3 Processing by heat treatment 
As previously mentioned, there is an increasing demand and interest to prepare porous 
scaffolds from bioactive glass. This could be achieved using several methods, including 
for example chemically-based sol-gel-method, polymer foam replication, freeze-casting 
and 3D-printing (Fu et al. 2011a,b; Jones et al. 2006).  In this thesis the focus of interest 
is thermal bonding, i.e. sintering. With this processing method, a scaffolds with various 
geometry can be prepared without the need of complex machinery. (Baino & Vitale-
Brovarone 2011). 
Glasses are conventionally produced by melting precursor compounds in high tempera-
tures and fast quenching. The obtained structure is liquid-like. Sintering refers to thermal 
bonding of glass particles, where material is heat treated from room temperature to an 
elevated temperatures, resulting in spontaneous adhesion and a solid structure. If a desired 
geometry or a shape is made from the glass particles, it is referred as forming. Sintering 
occurs by thermal activation, i.e. heating, of molecules; the reduction of surface energy 
gradients drives the grain interfaces to contact and eventually fuse together. In the late 
stages of sintering, pores between the particles are closed and grains become tightly 
bonded. Grain boundary diffusion and other related phenomena depend of for example 
processing temperature, atmosphere and of composition of the material. Sintering is a 
processing method that can be used to produce materials with controlled microstructure 
and porosity. (Bellucci et al. 2010; Hench & Wilson 2013, p. 15-22; De Jonghe & Ra-
haman 2003). The sintering process is illustrated in Figure 5. 
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Figure 5. Stages of sintering. Early stages, development of contact (1,2), followed by 
contact growth (3) and eventually, sintered product (4). Modified from figure available 
at keramvarband.de, 2016.  
 
All glasses pertaining to their amorphous structure exhibits a glass transition temperature 
or domain (Tg) which is the interval where a system transforms from a supercooled liquid 
to a solid glass (Brauer 2015). Viscous flow sintering happens above this temperature. At 
certain temperature, the network starts to form in more orderly structure. This temperature 
is referred as onset of crystallization (Tx). These temperatures are characteristic for each 
glass composition, and depend also from several conditions, such as the volume or size 
of the analyzed glass specimen. Glasses, by definition, are distinguished from other ce-
ramics by having random network. Crystallization in the structure can happen during the 
preparation of glass, or in further processing steps. Therefore, processing window for heat 
treatment or hot forming for glass is referred as the temperature range between Tg and Tx 
(Arstila et al. 2007; Rahaman et al. 2011). Crystallized glasses or a glass-ceramics have 
more arranged or ordered network, and are, typically, less reactive to surrounding condi-
tions. Due to their low silica content, bioactive glasses such as 45S5 and S53P4 are sus-
ceptible to crystallization during heat treatments and forming operations. The tendency 
depends on the glass composition, but also from glasses surface condition. For example, 
surface defects are prone to function as a nucleation site. (Arstila et al. 2008; Fagerlund 
et al. 2012; Massera et al. 2012a, 2015a).   
3.4 Current commercial products 
The first bioactive glass – BioGlass® 45S5 – developed by Larry Hench in 1969, was 
approved to clinical use already in 1985 and is currently sold under trade names such as 
NovaBone and PerioGlas (Hench & Jones 2015; Jones 2013). The composition of 45S5, 
presented in molecular percentage (mol-%) is SiO2 46.3%, Na2O 24.3%, CaO 26.9% and 
P2O5 2.5%. Since then, few other glass composition have been approved to clinical use; 
for some to mention, bioactive glass 13–93 and S53P4 (BonAlive®). 13-93 (composition 
of SiO2 54.6%, CaO 22.1%, K2O 7.9 %, MgO 7.7%, Na2O 6%P2O5 1.7% in mol-%) is a 
silicate glass based on 45S5, with higher SiO2 and additional network modifiers, is ap-
proved for in vivo use in Europe. (Brown et al. 2008; Rahaman et al. 2011). S53P4, the 
first non-45S5 composition to reach markets, is osteostimulative bioactive glass with 
composition of SiO2 53.9%, Na2O 22.7%, CaO 21.8%, P2O5 1.7% in mol-%. (BonAlive 
Biomaterials 2016; Hench & Jones 2015).  
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Already, bioactive glasses have been utilized in many dental and tissue engineering ap-
plications, such as in repair of a variety of craniofacial, maxillofacial, and periodontal 
defects. (Baino et al. 2015; Brauer 2015) However, despite being available for over 30 
years, clinical applications for these materials are still restricted mostly to glass granules 
and pastes, where glass is present in form of fine powder. (BonAlive Biomaterials 2016; 
Hench & Jones 2015). 
Feature in common with commercial bioactive glasses is that they are usually silica-
based. They, otherwise excellent materials, have been found to possess some restrictive 
properties, such as tendency to crystallize. Crystallization of bioactive glasses is prob-
lematic, as the more stable structure is in chemical respect less reactive. Commercial 
glasses, such as 45S5, crystallize because of their low thermal stability and therefore are 
not suitable to be used in applications or products which require heat-treatments. (Arstila 
et al. 2008; Fagerlund et al. 2012; Massera et al., 2012a; Vedel et al. 2007). Additionally, 
in clinical trials utilizing S53P4 as bone graft substitute in benign bone tumor surgery, it 
was found that even after being 14 years in vivo, remnants of the used glass granules were 
still observed in some patient cases. (Lindfors et al. 2010). This indicates that the used 
glass did not completely degrade, as bones’ remodeling system was not able to completely 
overturn it. This is partly attributable to non-congruent dissolution mechanism of silicate 
bioactive glasses and the formation of the HA layer as well as the SiO2-rich layer, which 
will act as a barrier to the glass dissolution. The degradation rate is a property that can be 
controlled by making changes in the glass composition. This way, it should be possible 
to match the degradation rate of bioactive glass with the bone regeneration rate. (Rahaman 
et al. 2011).  
3.5 Modification of the glass composition 
Besides degradation rate, the bioactivity of the glass can be changed by tailoring the com-
position in a way that the material also can serve as a source of many of the minor ele-
ments known to favor bone growth. As the glass degrades in vivo, these elements are to 
be released at a biologically acceptable rate. (Rahaman et al. 2011).  
3.5.1 Borate-based bioactive glasses 
Borate-based glasses have been shown to have especially desirable bioactive properties. 
They can be produced by replacing the SiO2 in silicate glass with B2O3 partially or fully, 
yielding respectively a borosilicate or borate bioactive glass. Like other bioactive glasses, 
borate glasses have been shown to support cell proliferation and differentiation in vitro, 
and tissue infiltration in vivo. (Marion et al. 2005; Fu et al. 2009, 2010). There has been 
some concern about boron’s toxicity as released boron ions in the solution. This has some-
times been the case in conventional, static in vitro cell cultures, however in dynamic cul-
tures and in vivo conditions, the toxicity has been diminished. (Huang et al. 2006). In fact, 
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borate bioactive glasses have been found to possess enhanced bone formation properties 
when compared to silicate bioactive glasses; controlled release of boron ions have dis-
played osteogenic and angiogenic properties. (Durand et al. 2015; George 2015; Raha-
man et al. 2011;  Zhang et al. 2010). The borate-based glasses have lower chemical du-
rability than in silicate 45S5, or 13-93 glass. This contributes in a way that the borate 
glasses degrade faster than the commercial silica glasses, and in addition can convert 
more completely to HA-like material. Hence, borate glasses are eventually more likely to 
be replaced by the bone remodeling mechanism. (Liang et al. 2008; Rahaman et al. 2011). 
3.5.2 Addition of alkali earth metals 
Calcium, one typical elements in bioactive glasses, can be found in group 2A of the peri-
odic table; belonging thus to alkaline earth metals. In modification of glass composition, 
e.g. the calcium can be replaced or substituted with other elements from the same group, 
which share chemically similar properties. (Brauer 2015; Brink 1997; Rahaman et al. 
2011). 
Partial substitution of the CaO with MgO has not been found to greatly affect the ion 
release kinetics, but can slightly increase the overall durability of the material. Mg seems 
to contribute towards stronger glass network, which makes materials reactivity in SBF 
decrease to some extent, however providing also better resistance to crystallization. In 
addition, the glass transition temperature decreases, as the crystallization peak emerges 
in higher temperature; giving the material wider thermal processing range. (Hupa et al. 
2016; Massera et al. 2012b.). Mg is an interesting elements for bone tissue engineering 
applications as it additionally has an important role in bone development, by stimulating 
osteoblast proliferation and angiogenesis. (Ma et al. 2010; Massera et al. 2012b) 
In the other hand, strontium shares some biological effects that are related to the chemical 
similarities to calcium. In bioactive glass, the strontium exists in form of SrO. Replacing 
CaO with SrO has been found to increase the initial dissolution rate of the glass in SBF, 
indicating faster reaction with the physiological fluids, and thus faster degradation in 
physiological conditions. Therefore, doping the glass with Sr can enable the modification 
of the glass resorption rate to match with the new bone formation, while simultaneously 
releasing Sr ions which can be beneficial to the ossification. Sr has also been found to 
substitute some of the Ca in HA layer. (Fredholm et al. 2010, 2012; Hupa et al. 2016; 
Isaac et al. 2011; Massera & Hupa 2014). Strontium has so called bone-seeking proper-
ties, and therefore it has been found interesting for the purpose of treating osteoporosis 
already in the 1950s (Goel, et al. 2011). It has been shown that ions released from bioac-
tive glass, where some of the Ca has been substituted with Sr, enhance the metabolic 
activity in osteoblasts while inhibiting the activity in osteoclasts, promoting thus new 
bone formation and strengthening of the original tissue; property useful e.g. in treatment 
of osteoporosis (Bonnelye et al. 2008; Gentleman et al. 2010; Massera et al. 2015b). 
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4. MATERIALS AND METHODS 
The objective of the study was to assess the impact of Mg and Sr on the thermal and 
dissolution properties of a borosilicate bioactive glass. The aim was to define a glass with 
thermal properties enabling thermal sintering without inducing crystallization while con-
verting more completely to hydroxyapatite without too large release of boron. 
A base borosilicate glass with potential for tissue engineering was used as starting glass 
composition. The Ca was replaced with up to 10 mol% of Mg and or Sr. The thermal 
properties as well as the dissolution in simulated body fluid (SBF) of the glasses were 
studied for two particle sizes. 
4.1 Preparation of the samples 
Borosilicate glass with composition of 47.12 SiO2 – 6.73 B2O2 – 21.77CaO – 22.65 Na2O 
– 1.72 P2O5 in mole percentage (mol%) was used as a base glass for this study. The glass 
was referred as B12.5. This composition is a modification of the commercial silicate bi-
oactive glass S53P4 (BonAlive Biomaterials Ltd, Turku, Finland), where 12.5 mol% of 
the SiO2 was substituted with B2O3. Tests with glasses containing larger substitution of 
B2O3 for SiO2 have been conducted in the Master’s thesis of Ojha, 2016.  
Six different glass compositions based on B12.5 were prepared for the study. The glasses 
of investigation follow the general equation: 47.12 SiO2 – 6.73 B2O2 – 21.77 (-x-y) CaO 
– 22.65 Na2O – 1.72 P2O5 – x MgO – y SrO (mol%), where x,y = 0, 5 or 10 mol%. The 
glass composition are presented in Table 1.  
Batches were prepared from mixtures of sand (99,4 % of pure SiO2) and analytical grades 
of reagents acquired from Sigma Aldrich (H3BO2, MgO, SrCO3, (NH4)H2PO4, Na2CO3) 
and ThermoFisher (CaCO3). The glasses were melted in a platinum crucible, in a Naber-
therm P310 (Nabertherm GmbH, Lilienhal, Germany) electric furnace. Melting was con-
ducted in air, from room temperature (RT) at rate of ~10 °C/min to 800 °C, where melt 
was let to stabilize for 15 min. The aim of this isothermal step was to let the reagent 
decompose and control the batch foaming. The batch was then heat up to 1300 °C at a 
heating rate of ~26 °C/min and held for 30 min. The melt was then casted into a graphite 
mold and annealed at 500 °C for 5 hours in Nabertherm P330 electric oven, and let to 
cool to RT overnight. The heat treatment is also presented in Table 2. 
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Table 1. Compositions (in mol%) of the novel borosilicate glass batches. 
Glass / com-
position 
B12.5 B12.5 -
Mg5 
B12.5-
Mg10 
B12.5- 
Sr5 
B12.5-
Sr10 
B12.5-Mg5-
Sr10 (‘mix’) 
SiO2 47.12 47.12 47.12 47.12 47.12 47.12 
B2O3 6.73 6.73 6.73 6.73 6.73 6.73 
CaO 21.77 16.77 11.77 16.77 11.77 6.77 
Na2O 22.66 22.66 22.66 22.66 22.66 22.66 
P2O5 1.72 1.72 1.72 1.72 1.72 1.72 
MgO - 5 10 - - 5 
SrO - - - 5 10 10 
 
 
Table 2. Thermal cycle for the processing of the glasses. 
Protocol Time End temperature 
Heating ~ 10 °C /min 80 min 800 °C 
Stabilization  15 min 
Heating ~ 26 °C /min 50 min 1300 °C 
Stabilization 30 min 
Casting to a graphite mold, and then annealed in preheated electrical oven 
Annealing ~ 5 h 500 °C 
Cooling overnight RT 
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After melting, the glasses were grinded to two different particle sizes. The block obtained 
from melting was crushed first in a mortar and pestle to obtain coarse particles, sieved 
with test sieves (Retsch Gmbh, Germany). Particles in the range 250-500 µm were col-
lected. The rest of the glass was milled further with ball mill (KM 1, Janetzki, Poland) 
and mortar and pestle to obtain finer particles of diameters smaller than 38 µm. These 
particle sizes were used to study the thermal properties, sintering and dissolution of the 
glass compositions. The accurate particle size distribution of the grinded glasses was an-
alyzed with Mastersizer 2000 with Hydro 2000S module (Malvern Instruments, Worces-
tershire, United Kingdom). 
4.2 Physical properties 
The final density of the prepared compositions was measured using two different meth-
ods; Archimedes' principle in water for the bulk material, melt-derived glass blocks with 
three to four parallel measurements, and helium pycnometry for untreated coarse glass 
particles. The gas displacement helium pycnometer AccuPyc 1330 (Micromeritics, Geor-
gia, USA) was used with an accuracy of ± 0.01 g/cm3. 
Archimedes’ principle is based on the assumption that an object of density (ρ) in a fluid 
has a buoyant force equal to the weight of displaced fluid, while 
mfluid = Apparent weight in fluid of density ρo  
mair = Weight of object determined in air 
 
𝜌 =  𝜌𝑜 ∗
𝑚𝑎𝑖𝑟
𝑚𝑎𝑖𝑟−𝑚𝑓𝑙𝑢𝑖𝑑
                          (1) 
 
Based on the results, molar volume (Vm) was calculated using the following equation: 
 
𝑉𝑚 =
∑ 𝑥𝑖𝑀𝑖
𝜌
       (2) 
 
where ρ is the measured density, xi is molar fraction of i glass component and Mi is the 
molecular weight for component i. (Sharmin et al. 2013). 
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4.3 Structural properties 
Molecular vibrations in the glasses of investigation were assessed via Raman spectros-
copy (InVia confocal Raman microscope, Renishaw, UK). The measurements were per-
formed on block materials. The wavelength of the laser was 514 nm, the laser power was 
100 W, the exposure time was 10 s and 20 accumulations were recorded for within the 
range 200-1500 cm-1. All spectrum were baseline corrected and normalized to the band 
with maximum intensity. 
To complement the structural analysis, Fourier transform infra-red (FTIR) Spectrum One 
FTIR (PerkinElmer, Inc., USA) in attenuated total reflectance (ATR) mode was used. 
Measurements were performed on powdered glasses for untreated fine particle size < 38 
µm. All FTIR spectra were recorded within the range 600-4000 cm-1, corrected for Fres-
nel losses and normalized to the absorption band showing the maximum intensity. 
4.4 Thermal properties and sintering 
For determination of sintering temperatures, differential thermal analysis (DTA) was 
needed. Sintering was then conducted for both coarse and fine glass particles of all studied 
compositions. 
4.4.1 Differential thermal analysis 
SDTA was conducted for both coarse and fine particle sizes with STA 449 F1 Jupiter 
Simultaneous Thermal Analyzer (Netzsch Group, Selb, Germany) in Pt-Rd crucibles. The 
heating was conducted at a rate of 10 °C/min from 40 °C to 1200 °C in N2 atmosphere. 
Temperatures for the glass transition (Tg), onset of crystallization (Tx) and the crystalliza-
tion peak (Tp) were determined from the acquired data. Example of a thermograph and 
position of the temperatures of interest is presented Figure 6. 
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Figure 6. Example of a SDTA thermogram recorded for glasses with composition B12.5, 
indicating the position of the temperature of interest; glass transition temperature (Tg), 
onset of crystallization (Tx) and maximum of the crystallization peak (Tp). 
 
The glass transition temperature was taken at the inflection point of the first endothermic 
event. The onset of crystallization was taken at the beginning of the crystallization peak 
(tangent method) and the crystallization temperature at the maximum of exothermic peak. 
Working range (T) is an indication of the glass stability to crystallization and corre-
sponds to T=Tx-Tg. 
4.4.2 Sintering 
The glass particles were sintered in an electrical furnace (Nabertherm B410), in a stainless 
steel mold. The mold contained cylindrical holes of 10 mm depth and 5mm diameter, 
where internal sides were covered with boron nitride to reduce the attachment of glass to 
the mold surface.  
Several sintering conditions were tested for glass samples of size [250,500] µm, ‘coarse 
particles’ and < 38 µm, ‘fine particles’ before the proper test series. Fine particle size 
specimens were heated at the rate of 20 °C /min from RT to temperatures of Tx - 20 °C, 
Tx - 40 °C and Tx - 60 °C ±2 °C, temperatures characteristic for each glass composition, 
presented in Table 3. Here Tx corresponds to the onset of crystallization recorded using 
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the SDTA thermogram for the various glass composition using the fine particle size. The 
sintering temperature was held constant for 1h, then the samples were let to cool down to 
RT overnight. Similar heat-treatment was tested for the coarse glass of B12.5 at various 
temperatures ranging from 561 °C – 638 °C, i.e. from Tx-130 °C to temperature of Tx, 
where Tx corresponds to the onset of crystallization recorded using the SDTA thermo-
gram using the coarse particle size.  
 
Table 3. Sintering temperatures studied for all glasses with fine particles size < 38 µm. 
glass / T Tx - 60 (°C) Tx - 40 (°C) Tx - 20 (°C) 
B12.5 578 598 618 
B12.5-Mg5 590 612 632 
B12.5-Mg10 600 620 640 
B12.5-Sr5 562 580 604 
B12.5-Sr10 570 590 610 
B12.5-Mg5-Sr10 551 570 590 
 
Scanning electron microscopy (SEM) combined with energy-dispersive X-ray spectros-
copy (EDX), and X-ray diffraction (XRD) were performed to evidence crystallization 
and/or phase separation. For the EDX, sintered specimen were cut in half and the fracture 
surface of the samples were carbon coated. Samples were imaged with low vacuum JSM-
6510LV Scanning Electron Microscope (Jeol, Tokyo, Japan.). Imaging was obtained in 
both backscatter (not presented in thesis) and secondary electrons (presented) from the 
same spot. Magnifications of 250x and 2000x were used. XRD was performed with Min-
iFlex 300/600 (Rigaku Corp, Tokyo, Japan) for B12.5 coarse specimen; untreated and 
sintered specimen, and for all fine particle size sintered specimen. 
4.5 In vitro dissolution 
Dissolution test was performed in SBF for time points ranging from 6 hours to two weeks 
(~336 hours) on all untreated glasses of investigations. SBF solution was prepared fol-
lowing the protocol presented first in Kokubo et al. 1990 (presented in Appendix A). 
Reagents used in the preparation were acquired from VWR Chemicals (NaCl, NaHCO3, 
KCl, K2HPO4, MgCl, CaCl, Na2SO4) and MP Biomedicals (TRIS Ultra pure). 
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Glass samples of both coarse and fine particle size were introduced in 50 ml of SBF so-
lution. Amount of immersed glass ranged from 75 mg to 80.3 mg (±0.5 mg) with constant 
surface area between the compared glass compositions, following method the standard 
method (Macon et al. 2015). The mass of sample was adjusted to maintain the surface 
area of glass in contact with the solution constant. The surface area was defined based on 
the measured density of the glasses. For this, assumption that of the average particles size 
was 375 µm for the coarse and 19 µm for the fine and particles are spherical was made. 
The glass powder were placed in glass containers and specimens were immersed and 
placed in a shaker (Multitron AJ 118 g, Infors, Bottmingen, Switzerland) at 37 °C and 
100 RPM for approximate time points of 6, 24, 48, 72, 168 and 336 hours. All tests were 
performed in triplicates.  
At each time points, the pH of the dissolution solution was measured, at 37 °C (±0.2 °C) 
with Mettler Toledo SevenMulti MP 225 pH-meter (Mettler-Toledo International Inc., 
Greifensee, Switzerland). From same solution, the ion concentration after glass immer-
sion was analyzed with an inductively coupled plasma optical emission spectrometry 
(ICP-OES) (Agilent Technologies, USA). 5 ml of the dissolution SBF was diluted 10 
times for ion concentration analysis. Analyzed elements were Si, B, Ca, P, Mg and Sr. 
The wavelength used for the measurement are listed in Table 4. Concentration of Na ions 
present in glass compositions were not analyzed as the SBF itself already contains large 
amount of Na, therefore leading to saturation of the detector and large inaccuracy. 
 
Table 4. Wavelengths of interest for each elements to be analyzed with ICP-OES. 
Element Si B Ca P Sr Mg 
Wavelength (nm) 288.158 208.956 393.366 253.561 407.771 279.553 
 
The immersed glass specimen were filtrated and rinsed with acetone to stop further hy-
drolysis reactions. The glasses were then analyzed with FTIR-ATR spectroscopy to ana-
lyze of evidence of any structural changes at the particle surfaces. Analysis was conducted 
on both fine and coarse particle size. The IR absorption spectra were recorded within the 
range 600-4000 cm-1, corrected for Fresnel losses and normalized to the absorption band 
showing the maximum intensity. 
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5. RESULTS 
5.1 Glass characterization  
This section reports on the physical, structural and thermal properties of the glasses of 
investigation. Information gathered by glass characterization was used in planning of test 
conditions, an additionally in assessment of the obtained results. 
5.1.1 Density and molar volume 
Density and molar volume give an indication off the network compactness due to com-
positional change. Densities of the glasses were determined for melt-derived block with 
Archimedes’ principle (utilizing equation 1), and grinded, coarse glass particles with he-
lium pycnometer. Molar volume was calculated using equation 2, using the density ob-
tained by pycnometry. The density as well as the calculated molar volume are reported in 
Table 5 and presented in Figure 7. 
 
Table 5. Measured densities ρ (g/cm3) ± 0.02 with Archimedes’ principle (for glass as 
blocks, in bulk form) and helium pycnometer ± 0.01, and calculated molar volume Vm 
(mol/cm3) ± 0.2. 
Glass B12.5 -Mg5 -Mg10 -Sr5 -Sr10 -Mg5-Sr10  
Density 
Block  2.65 2.64 2.62 2.76 2.84 2.80 
Coarse 
particles 
2.66 2.65 2.62 2.75 2.84 2.82 
Molar volume 
 23.2 23.0 22.9 23.3 23.4 23.3 
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Figure 7. Density (top) and molar volume (bottom) of the prepared glass compositions.  
 
The density and molar volume of the base glass B12.5 was found to be 2.66 ±0.01 g/cm3 
and 23.2 ±0.2 mol/cm3, respectively. Partial substitution of Ca with Mg lead to a decrease 
in both the density and molar volume. Partial substitution of Ca with Sr while leading to 
a decrease in density does not seem to impact the molar volume, within the accuracy of 
the measurements. 
5.1.2 Structural properties 
Structural properties were analyzed by Raman and FTIR spectroscopy. The analyzed data 
was background corrected and normalized to the band with maximum intensity. Figures 
8 and 9 present Raman and FTIR spectra of the glasses of investigation, respectively. 
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Figure 8. Background corrected and normalized Raman spectra for all glass composi-
tions. 
 
All of the investigated glass compositions exhibit similar Raman spectra (Fig. 8). From 
the figure, several peaks can be observed. Within the region 300-850 cm-1, the small peaks 
between 300 and 500 cm-1 have been related to mixed stretching and bending modes of 
Si-O-Si bond. Additionally, peak around 500 cm-1 can be attributed to Si-O-Si bending. 
Peaks around 550-850 cm-1 have been found to indicate breathing ring modes of borate- 
and borosilicate ring units groups. Especially, high peak at 630 cm-1 attributes to breath-
ing mode of borosilicate rings.  (Bunker et al. 1990; Manara et al. 2009; Matson et al. 
1983; Meera et al. 1990, 1993.) 
On the region 850-1250 cm-1, peaks around 900-920 cm-1, 950-980 cm-1 and 1050-1100 
cm-1 indicate respectively Si-O stretching with one, two and three non-bridging O atoms 
per silicon (i.e. Q1, Q2 and Q3 structural units). High frequency band between 1120 and 
1190 cm-1 indicates fully polymerized Si-O unit (Q4). (Fukumi et al. 1990; Manara et al. 
2009; Mysen & Frantz 1992; Neuville et al. 2006, 2008.) 
Region of 1250-1500 cm-1 indicates B-O stretching with peak at around 1410 cm-1 
demonstrating BO3 units bonding BO4, and around 1480 cm
-1 BO3 units bonding BO3 
units. (Akagi et al. 2001; Manara et al. 2009; Meera et al. 1990; Yano et al. 2003). 
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Figure 9. Background corrected and normalized FTIR-ATR spectra of the untreated glass 
compositions. 
 
FTIR spectrum of the glass compositions are presented in Fig. 9. Spectra for all compo-
sitions is again highly similar. Peaks around 750 cm-1 may indicate Si-O bending, and 
absorption band at 950 cm-1 and around 1100-1150 cm-1 to Si-O- and Si-O- asymmetric 
stretching in SiO4 units. Band located within the 1400-1515 cm
-1 area can be attributed 
to carbonate within the structure. (Massera et al. 2012, 2014; Serra et al. 2003). 
However, absorption around 850-1150 cm-1 range can also be attributed to B-O stretching 
vibration of BO4 units, and band around 1400 cm
-1 can be related to borate triangles 
formed by BO3. Boron in form of BO2O
- can additionally be indicated by a slight band at 
1227 cm-1.  (Pascuta et al. 2008).  
5.1.3 Particle size distribution 
As the one of the aim of the study was to assess whether or not it is possible to sinter these 
glass compositions without inducing crystallization the thermal properties of the glasses 
should be studied. However, it is known that the sintering process as well as the crystal-
lization kinetics is particle size dependent (Boccacini et al. 1996; Ray et al. 1991). 
Determination of the particle size distribution for grinded glass specimen was analyzed 
with laser diffraction particle sizing. Results are presented as differential particle size 
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distributions as volume percent of the total analyzed particle amount in Figure 10. The 
D10, D50 and D90 representing the range (10% and 90%) and midpoint (50%) of the cu-
mulative particle sizes is presented in Table 6 and as column chart in Figure 11.  
 
 
Figure 10. Differential particle size distribution of the produced glass particles, showing 
the relative amount of each particle size. Graph is formed based on results for both fine 
and coarse particle size. 
 
Table 6. Cumulative particle size diameter (in µm) distributions of 10%, 50% and 90% 
of the particles. 
 B12.5 -Mg5 -Mg10 -Sr5 -Sr10 -Mg5Sr10 
fine particle size; sieved to < 38 µm 
D10 4.1 2.5 2.7 2.5 2.3 2.9 
D50 21.7 15.2 16.1 12.6 14.5 16.4 
D90 47.7 38.9 41.7 32.7 36.2 40.4 
coarse particle size; sieved to [250,500] µm 
D10 223.3 225.2 255.2 243.4 232.8 229.9 
D50 473.4 441.9 476.4 451.1 455.5 441.6 
D90 790.5 733.7 792.4 746.0 758.0 733.2 
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Figure 11. Cumulative particle size distribution (in µm) showing D10, D50 and D90 indi-
cated in blue, red and green, respectively. 
 
Coarse particles were collected by sieving the particle with sieves having a grid diameter 
of 250-500 µm. Fine powder corresponds to particles collected after passing through a 
sieve with a grid size of 38 µm. From Fig. 10 it can be seen that all coarse glass samples 
exhibited particles with similar D10, D50 and D90. The particles size ranges from 223 to 
792 µm with mass median diameter being 457 ±15 µm. For fine particles, the equivalent 
diameter sizes ranged from 2 to 48 with mass median diameter of 16 ±3 µm, glass com-
position B12.5 being slightly larger compared to the other compositions. 
5.1.4 Differential thermal analysis 
Differential thermal analysis was performed for glass compositions of both particle sizes 
with heating rate of 10 °C/min. The obtained DTA curves are plotted in Appendix B, and 
the determined Tg, Tx and Tp as well as the hot forming domain are presented in Tables 7 
and 8. Determination was performed as presented in materials and methods; Fig. 6 in 
chapter 4.4.1. Determined temperatures are also illustrated in Figures 12 and 13. 
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Table 7. Determination of glass transition temperature (Tg), onset of crystallization (Tx), 
crystallization peak (Tp) and hot forming domain, i.e. working range ∆T for coarse par-
ticles size. 
Glass composition Tg (±2oC) Tx (±2oC) Tp (±2oC) T = Tg-Tx (±4oC) 
B12.5 529 691 772 162 
B12.5-Mg5 513 678 781 165 
B12.5-Mg10 500 687 795 187 
B12.5-Sr5 512 659 780 147 
B12.5-Sr10 502 675 772 173 
B12.5-Mg5-Sr10 472/507 647 725 140 
 
 
Table 8. Determination of glass transition temperature (Tg), onset of crystallization (Tx), 
crystallization peak (Tp) and hot forming domain, i.e. working range ∆T for fine particles 
size. 
Glass composition Tg (±2oC) Tx (±2oC) Tp (±2oC) T = Tg-Tx (±4oC) 
B12.5 531 638 676 107 
B12.5-Mg5 511 652 683 141 
B12.5-Mg10 502 660 701 158 
B12.5-Sr5 514 622 667 108 
B12.5-Sr10 506 628 675 122 
B12.5-Mg5-Sr10 473/506 611 666 105 
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Figure 12. Tg, Tx and Tp for coarse glass particles. 
 
Figure 13. Tg, Tx and Tp for fine glass particles. 
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From the results, several observations can be made; (i) Within the range of accuracy, Tg’s 
were same for both particle sizes, with all glass compositions. (ii) A decrease in particles 
size lead to a shift of the Tx and Tp to lower temperatures. (iii) Substitution of Mg for Ca 
leads to a decrease in Tg and an increase in Tx, Tp and ∆T. (iv) Substitution of Sr for Ca 
leads to a decrease in Tg. However, while a general decrease in Tx and Tp can be seen as 
well as an increase in ∆T for higher for 10 mol% substitution, no clear trend could be 
evidenced. (v) The SDTA curve for glass composition B12.5-Mg5-Sr10 containing both 
Mg and Sr exhibited two different Tg’s. ∆T was calculated using the higher Tg. The mix-
ture glass exhibits lower Tg, Tx, Tp and ∆T than the based glass B12.5. 
5.2 Sintering and crystallization 
Based on thermal properties, glass particles of both coarse and fine size were sintered in 
a metallic mold. The temperatures used for sintering where all within the ∆T=Tx-Tg do-
main. With the used sintering conditions, the coarse particle size did not sinter at all or 
sintered poorly. Therefore, the sintering study was focused on the small sized particles. 
The samples were heat treated at Tx-60, Tx-40 and Tx-20 °C. SEM imaging was performed 
only for specimen sintered at Tx-40 °C. The aim was to evidence neck growth and coars-
ening of the particles. XRD analysis was performed for B12.5 coarse particles sintered at 
several temperatures and for various conditions, and fine particles of all glass composi-
tions, sintered at 60, 40 and 20 °C below their characteristic Tx. The aim was to assess 
the amorphousness or partial crystallinity of the produced sintered bodies.  
5.2.1 SEM 
SEM imaging with backscatter electrons was performed for fine particle size specimen 
with constant sintering time of 1h at Tx-40 °C. Specimen were imaged with magnifica-
tions of 250 and 2000 x. Results are presented in Figure 14 for B12.5 (A and B), B12.5-
Mg5 (C and D) and B12.5-Mg10 (E and F), and in Figure 15 for B12.5-Sr5 (A and B), 
B12.5-Sr10 (C and D) and B12.5-Mg5-Sr10 (E and F). 
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Figure 14. SEM imaging of fine particles size of glasses (A,B) B12.5 (C,D) B12.5-Mg5 
(E,F) B12.5-Mg10, sintered at their respective Tx-40 °C for 1h. Scale bars of 100 um 
(indicated as white) and 10 um (indicated as red). 
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Figure 15. SEM imaging of fine particles size of glasses (A,B) B12.5-Sr5 (C,D) B12.5-
Sr10 (E,F) B12.5-Mg5-Sr10, sintered at their respective Tx-40 °C for 1h. Scale bars of 
100 um (indicated as white) and 10 um (indicated as red). 
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From Fig. 14A and 14B, it can be seen that in the fracture surface of B12.5 the particles 
had started to form a contact, neck growth, with the surrounding particles. At higher mag-
nification (Fig. 14B), a pattern can be distinguished at the glass particle surfaces. Imaging 
using secondary electrons (not presented) indicated that the patterns were a result of to-
pography, instead of differences in elemental composition. 
Figures 14C-F illustrated smooth fracture surfaces of the Mg containing glass composi-
tions. Glasses containing Mg (Fig. 14C and 14E) exhibited a pronounced neck growth 
and coarsening of the particles. Trapped gas bubbles can be seen as well as small pores. 
It seems that with increasing the Mg content the amount of remaining pores decreases. 
However, it can be noted that, at higher magnification (Fig. 14D and 14F), clear sign of 
glass crystallization are seen. The crystallization pattern seem to follow possible grain 
boundaries. This was observed to increase as the Mg content increased. 
Sr containing glass specimen are presented in Fig. 15. The specimen of B12.5-Sr5 in Fig. 
15A-B bored high resemblance to specimen B12.5 presented in Fig. 14A-B. Glass which 
contained more Sr, the B12.5-Sr10, demonstrated more advanced sintering of the particles 
than B12.5-Sr5. It should however be noted that in images of the higher Sr containing 
glass, some of the smooth looking surface is not result from fused particles, but from a 
fracture that proceeds through middle of a glass grain (best seen in Fig. 15D); outcome 
of cutting a solid particle in half while preparing the specimen. 
Mixture glass where some of the Ca content was substituted with both Mg and Sr is pre-
sented in Fig. 15E-F. Sintering of the glass was fairly good, as some of the particles have 
clearly fused together. However, in the specimen there can be seen areas of clear differ-
ence in colour gradient. In SEM this indicates difference in materials density. Change in 
gradient does not in this case follow the grain boundaries (Fig. 15F). This phenomena 
was not observed with imaging with secondary electrons (not presented), therefore it is 
not likely cause by surface topography. 
5.2.2 XRD 
XRD analysis was performed for B12.5 coarse particles sintered at Tx -130 °C, Tx - 60 °C 
and Tx. At Tx - 60 °C, sintering time ranged from 1 h to 3h. Analysis was also performed 
for untreated glass specimen. The XRD diffractogram are presented in Figure 16.  
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Figure 16. XRD spectra of B12.5 coarse particle size sintered from Tx-130 
oC to Tx for 
duration varying between 1 to 3h at Tx-60 
oC. 
 
From Fig. 16, it can be seen that the coarse particles heat treated up to Tx-130 °C for 1h 
only exhibit a broad band. At increasing sintering temperature sharp peaks starts to form, 
which increases in intensity with increasing sintering temperatures. At Tx-60 °C an in-
crease in sintering time also leads to an increase in the diffraction peaks intensity.  
The diffractogram obtained for the sintered bodies obtained using fine particle size, con-
stant sintering time of 1h and sintered at Tx - 60, 40 and 20 °C are presented in Figures 
17-22. 
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Figure 17. XRD spectra of B12.5 fine particle sintered at Tx - 60, 40 and 20 °C. 
 
Figure 18. XRD spectra of B12.5-Mg5 fine particle sintered at Tx - 60, 40 and 20 °C. 
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Figure 19. XRD spectra of B12.5-Mg10 fine particle sintered at Tx - 60, 40 and 20 °C. 
 
Figure 20. XRD spectra of B12.5-Sr5 fine particle sintered at Tx - 60, 40 and 20 °C. 
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Figure 21. XRD spectra of B12.5-Sr10 fine particle sintered at Tx - 60, 40 and 20 °C. 
 
Figure 22. XRD spectra of B12.5-Mg5-Sr10 fine particle sintered at Tx-60, 40 and 20 °C. 
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As can be seen from Fig. 17-22, with all fine particle specimen, crystallization started to 
occur already at sintering temperature of Tx-40 °C for all glasses except for the glass 
Mg10 for which crystallization started at Tx-60
oC. Sharp peaks indicating crystallization 
were most intense in glasses B12.5 and Mg containing variants. Glasses containing Sr 
had slightly less crystallization, and glass containing both Mg and Sr spectra indicated 
mainly an amorphous structure. 
5.3 In vitro properties 
All glasses of investigation were immersed in SBF from 6 h up to 2 weeks. Dissolution 
of the glasses was assessed by interpreting change in the pH and ion concentration in the 
SBF. FTIR spectra was recorded on all glass powders to better understand the change in 
glass structure upon dissolution and if a reactive layer deposit at the surface of the glasses 
particles 
5.3.1 pH  
Figure 23 presents pH of the SBF upon immersion of coarse glass particles for 24 h up to 
two weeks. Figure 24 presents, similarly, the pH of the SBF upon dissolution of the fine 
particles for 24 hours up to 1 week. All pH were measured at 37 ±0.2 °C. 
 
Figure 23. pH of the SBF containing coarse glass particles as a function of immersion 
time. pH was measured after approximate time points of 24, 48, 72, 168 and 332h. 
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Figure 24. pH of the SBF containing fine glass particles as a function of immersion time. 
pH was measured after approximate time points of 6, 24, 48, 72 and 168h. 
 
With both particle sizes, the pH was observed to increase with increasing the immersion 
time. From Fig. 23 can be observed that the pH seems to rise progressively with time, 
without saturation. Glasses containing 5 mol% of Sr or Mg expressed similar pH than the 
B12.5 glass. The glass containing 10 mol% of Mg show lower pH value compared to the 
base glass, while glass containing 10 mol% Sr and the mixture glass (B12.5-Mg5-Sr10) 
demonstrated even lower pH at the longest immersion times. 
Results presented in Fig. 24 indicate, that the increase in pH occurs at faster rate than the 
one observed in coarse particles. The rise in the pH was found to be faster for glasses 
B12.5-Mg5, -Mg10, -Sr5, -Sr10 and –Mg5-Sr10 initially than of the glass B12.5. At im-
mersion time longer than 72h, all of the investigated glasses demonstrate a saturation of 
the pH, except the base glass B12.5 which seemed to still induce pH increase at 1 week 
immersion. 
5.3.2 ICP-OES 
Si, B, P, Ca, Mg and Sr ion content concentration for the immersion solution were deter-
mined with ICP-OES. Results for all ions for all of the investigated glass composition, as 
a function of time for constant surface area to volume ratio, are presented in Appendix C.  
44 
In this chapter, the comparison of ion release of Si, B, Ca, P, Mg and Sr from dissolved 
coarse glass particles is presented in Figures 25-30, respectively. Zero-time point marks 
the SBF ion content before immersion of glass specimen. 
 
 
Figure 25. Silicon ion concentration (ppm) presented as a function of immersion time. 
Graph presents ion release of coarse glass particles in SBF. 
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Figure 26. Boron ion concentration (ppm) presented as a function of immersion time. 
Graph presents ion release of coarse glass particles in SBF. 
 
Figure 27. Calcium ion concentration (ppm) presented as a function of immersion time. 
Graph presents ion release of coarse glass particles in SBF. 
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Figure 28. Phosphorus ion concentration (ppm) presented as a function of immersion 
time. Graph presents ion release of coarse glass particles in SBF. 
 
Figure 29. Magnesium ion concentration (ppm) presented as a function of immersion 
time. Graph presents ion release of coarse glass particles in SBF. 
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Figure 30. Strontium ion concentration (ppm) presented as a function of immersion time. 
Graph presents ion release of coarse glass particles in SBF. 
 
From Fig. 25, it can be seen that the concentration of released silica from the coarse par-
ticles is initially similar in all glass compositions. Between time points of 24 – 48h, the 
Si concentration in B12.5-Sr10 starts to slightly decrease in comparison to other glass 
compositions. From Fig. 26, it can be seen that similar phenomena happens with boron 
ions. However, with boron more clear difference between glass compositions can be ob-
served. Now, when increasing amount of the Ca had been substituted, the ion concentra-
tion of B in the dissolution solution decreased.  
Fig. 27 present the calcium ion concentrations of the dissolution solutions. It can be seen 
that for glass where Ca content was substituted up to 5%, (i.e. compositions B12.5, -Mg5, 
-Sr5), the free Ca ion concentration in the solution increases, whereas with glasses B12.5-
Mg10 and –Mg5-Sr10 Ca concentration remains fairly constant. Overall, the Ca concen-
tration decreases with composition containing less Ca. Fig. 28 presents the P concentra-
tion. Amount of P in solution decreases as function of immersion time, and additionally 
with increasing Ca content in glass composition. An increase in Mg and Sr lead to lesser 
decrease in P ions, as compared to the B12.5 glass. The mixture glass with highest Ca 
substitution expresses the lowest decrease in P ions concentrations. 
Fig. 29 and 30 present Mg and Sr ion concentration of coarse glass particle dissolution 
solutions. It can be observed that Mg release was initially slower in mixture composition 
containing both Mg and Sr. For Sr, release was of same rate in both B12.5-Sr5 and –Sr10, 
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and slightly slower in the mixture composition.  However, results for fine glass particles 
(not presented), presents slightly different results. The results were indeed more in agree-
ment with the glass composition, where B12.5-Mg5 released half of the Mg of B12.5-
Mg10 and similarly B12.5-Sr5 released half the Sr ions than B12.5-Sr10. The mixed glass 
showed a Mg and Sr release similar to the glass B12.5-Mg5 and B12.5-Sr10. In general, 
it can be stated that release of all ions was observed to be faster in fine, than in coarse 
glass particles.  
5.3.3 FTIR 
Changes in the glass surface composition as a function of immersion time in SBF were 
assessed with FTIR. All spectra were background corrected and normalized to the band 
with maximum intensity. Figure 31 presents the FTIR spectra of coarse particle of glass 
B12.5, for various immersion times from 0 to 336 h (i.e. up to 2 weeks). Figure 32 pre-
sents similar spectra for fine glass particles immersed up to 168 h (i.e. 1 week).  
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Figure 31. FTIR-ATR spectra of the glass B12.5 coarse particles (250 -500 µm) im-
mersed for up to 332h in SBF. 
49 
800 1200 1600 2500 3000 3500 4000
0,0
0,2
0,4
0,6
0,8
1,0
 
 
A
.U
.
Wavenumber (cm
-1
)
B12.5 (< 38 µm) immersed in SBF
 t=0
 t=6h
 t=24h
 t=48h
 t=72h
 t=168h
 
Figure 32. FTIR-ATR spectra of the glass B12.5 fine particles (< 38 µm) immersed for 
up to 168h in SBF. 
 
Fig. 31 presents the FTIR spectra for glass B12.5 on coarse particles, immersed for up to 
332 h and Fig. 32 for fine particles immersed for up to 168 h in SBF. With increasing 
immersion time, there can be observed that (i) the band located at ~950 cm-1 decreases in 
intensity, (ii) the band located at ~1100 cm-1 increases in intensity and shifts to ~1200 cm-
1, (iii) the shoulder at ~1200 cm-1 increases in intensity, and (vi) formation of peak in the 
1600-1700 cm-1, as well as a broad band in the 2500-3500 cm-1 region. 
As mentioned earlier, the band at 950 cm-1 corresponds to Si-O-Si vibration whereas the 
band at 1100-1200 cm-1 to Si-O- (Massera et al. 2012b, 2014). The peak centered at 1020 
cm-1 and 960 cm-1 for the longer immersion time are related to phosphate vibration and 
the shoulder at 1212 cm-1 can be related to presence of SiO4 as Q
4 units, respectively. 
(Berzina-Cimdina & Borodajenko 2012; Massera & Hupa 2014; Raunaud et al. 2002). 
The peaks around 1630 cm-1 and the broad band on range 2600 - 3600 cm-1 are indications 
of H-O-H as absorbed water in the structure. (Ratner et al. 2004). Similar phenomenon 
was observed in other glasses of investigation. The change was faster with dissolution of 
finer particles. 
Figure 33 present spectra of coarse particles of all investigated glass compositions, im-
mersed for 168h, and Figure 34 presents spectra of fine particles, immersed for 168h, for 
glass compositions B12.5, -Mg5, -Sr10 and B12.5-Mg5-Sr10. 
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Figure 33. FTIR spectra of all glasses (250-500 µm) immersed 168h (1 week) in SBF. 
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Figure 34. FTIR spectra for fine particles of glasses B12.5, B12.5-Mg5, B12.5-Sr10 and 
B12.5-Mg5-Sr10 immersed 168h in SBF. 
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In Fig. 33, the normalized spectra reveal changes around peaks of Si-O and/or B-O (850-
950 cm-1) at slightly different pace between investigated glass compositions. From after 
a bit longer immersion time, after 168h observed from Fig. 33, it seems that small addition 
(5% substitution of the Ca content) of Sr and Mg might speed up the disappearance, in 
comparison of other investigated glass compositions. In this time point, B12.5-Sr10 rep-
resents the highest peak at 850-950 cm-1 range. 
Fig. 34 presents FTIR spectra for fine particles of glasses B12.5, B12.5-Mg5, B12.5-Sr10 
and B12.5-Mg5-Sr10 immersed 168h in SBF. From this, we can observe that spectra for 
B12.5 and –Mg5 are highly similar. This was also the case with composition –Mg10 (not 
presented). B12.5 possesses slightly higher peak around 1460 cm-1, attributable to CO3 
(Ratner et al. 2004), than other investigated glass compositions. Furthermore, addition of 
Sr seems to cause a slight shift in peak related on the range of the PO4
3-, phosphate group 
as orthophosphate (1000-1100 cm-1).  
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6. DISCUSSION 
It is well known that the physical and thermal properties of glasses are strongly dependent 
on their structure and composition. (Massera et al. 2011). The aim of the study was to 
assess whether the introduction of Mg and Sr had positive impact on the thermal and 
dissolution properties of a borosilicate bioactive glass. Studied glass compositions were 
modifications of commercial BonAlive® S53P4, glass that is already utilized in clinical 
applications with good results (Lindfors et al. 2010). Similar glasses with modified boron 
content, and without substitution of alkali earth metals have been studied in thesis of Ojha, 
2016. Study by Ojha showed that boron substitution for SiO2 led to enhanced thermal 
properties as well as conversion of the glass to hydroxyapatite upon dissolution in SBF. 
For further enhancement of the glass properties, Sr and Mg have been introduced to tailor 
glass dissolution and thermal properties. 
6.1 Characteristic properties of studied glasses 
Sr and Mg substitution for Ca led to significant changes in the physical properties (table 
5). When some of the Ca was substituted with Mg, a lighter element, the density and 
molar volume decreased. The decrease in density can be correlated to the lighter mass of 
Mg compared to Ca, while the decrease in Vm indicates a contraction of the glass network, 
most likely due to the smaller size of the Mg ion compare to Ca. Sr is heavier than Ca and 
therefore an increase in the density was expected. However, no change in Vm, within the 
error of the measurements could be evidence. In conclusion, these results are consistent 
with both the molecular mass and size of the elements. Molar volume refers to the volume 
occupied by one mole of substance. In this case, it is directly linked to the glass network; 
Vm indicates the physical size of the network one mole of this specific glass composition 
forms. When linked with density, these properties correlates to how dense or open the 
glass network is (Sharmin et al. 2013). In other studies, substitution of modifier cations 
that have same valence but difference size (as it is the case in Sr and Mg substitution for 
Ca), the network, depending on the size of the cations, has been shown to become more 
compact, or expand. (Brauer 2015; Fredholm et al. 2010; Morikawa et al. 2013; Xiang & 
Du 2011). From Fig. 7 can therefore be interpreted that Mg substitution leads to a less 
open network which might have lower dissolution rate, whereas Sr had no notable effect 
on the network compactness.  
The structural properties of the investigated glasses were analyzed with both Raman and 
FTIR spectroscopy. The observed peaks, presented in Fig. 8 and 9, could be attributed 
mostly to bonds related to the boron and silicon network forming ions. Where FTIR gives 
good indication on the amount of bridging and non-bridging oxygen in the silica network, 
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as well as boron conformation (BO3 vs BO4 units, ring vs. linear structure) Raman spec-
troscopy gives more specific information on the amount of Qn units, where n =0 to 4 and 
corresponds to the number of bridging oxygen. From Fig. 8 presenting the Raman spectra 
of all glasses of investigation, it appears that major changes occur in the 500-700 cm-1 
region, where the band centered at 630 cm-1 increases in intensity with Ca substitution. 
The change is more pronounced for the Sr containing glasses. This band is related to 
breathing mode of borosilicate rings. (Bunker et al. 1990; Manara et al. 2009; Matson et 
al. 1983; Meera et al. 1990, 1993). This could indicate an increase in the boron structural 
units in the glass structure when Mg (10 mol%) and/or Sr are introduced instead of Ca in 
the glass structure. This is further confirmed by the changes the relative band intensity in 
the 800-1200 cm-1 region, as the band at 1090 cm-1 increases in intensity compare to the 
band with maximum intensity at 950 cm-1. This could be attributed to an increase in the 
overall silica network connectivity, evidenced by an increase in Q3 units at the expense 
of the Q2 units. Furthermore, the band related to the breathing modes of borosilicate rings 
shifts to lower wavenumber whereas the bands attributed to the silica network shifts to 
higher wavenumber (Fig.8). This may be contributed to the borate network that is en-
riched in alkaline earth elements, leading to structural distortion. The silica network, per-
taining to the shift seem to become more stable upon substitution of the Ca with Mg 
and/or Sr. (Hill & Brauer 2011). 
The FTIR spectra presented in Fig. 9 tend to further confirm the speculations, as the ratio 
between the intensity of the peak at 950 and at ~1050 cm-1 (I950/I1050) decrease from 1.25 
to 1.20 when Ca is replaced with Mg, and it decreases from 1.25 to 1.17 when Ca is 
replaced with Sr. For the mixture glass B12.5-Mg5.Sr10 the ratio is of 1.15. The decrease 
in this ratio indicates that the band at higher wavenumber increases in intensity, compared 
to the main band, indicating an increase in oxygen bridged to silica and a decrease in non-
bridging oxygen in the silica network. This is in agreement with an increase in Q3 units. 
(Fukumi et al. 1990; Manara et al. 2009; Mysen & Frantz 1994; Neuville et al. 2006, 
2008.) 
In order to study the glass crystallization tendency upon heat treatment, DTA must be 
performed. However, sintering and crystallization, two thermally activated process, are 
known to be glass particles size dependent (Boccacini et al. 1996; Chatzistavrou et al. 
2006; Rabinovich 1985). Most of the test were conducted with glass particles of two dif-
ferent sizes. Particles were produced by crushing glass with mortar and pestle, then sieved 
to either < 38 µm sieve (fine particles) or with 250 and 500 µm sieves (coarse particles). 
The analysis of particle size distribution however revealed that for coarse particles, the 
diameter ranged between 223 and 792 µm, mass median being approximately 460 µm 
(table 6). This indicates that the average particle size was on the upper limit of expected 
size, and batches contained additionally much larger particles than expected. This can be 
attributed to the particles being produced by mechanically crushing, therefore leading to 
needle like shaped particles rather than spherical.  
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For fine glass particles, diameter ranged from 2 to 48 µm, with mass median of 16 µm. 
Additionally, from Fig. 7 can be seen that particles of glass composition B12.5 were 
slightly larger than with other compositions. This is likely cause by the production 
method, than anything related to glass composition. However, the small variation in mean 
particles size should not impair the comparison of the thermal and dissolution properties 
of the glasses of investigation. This is especially true as the cumulative size distribution 
shows that the differences between D10, D50 and D90 is not significant. 
6.2 Thermal properties and sintering 
The current commercial melt-derived glasses have been shown to be challenging in hot 
forming processes because of their high tendency to crystallize, as a result of their com-
position. Crystallization in the other hand has been shown to lead to loss of glasses bio-
active properties. (Hupa et al. 2016; Massera et al. 2012a). This is problematic when 
considering preparation of products based on bioactive glasses, e.g. porous implant ma-
terials for the needs of tissue engineering applications, by forming process such as heat 
sintering. Therefore, the utilized bioactive glasses would need to tolerate thermal treat-
ments without crystallization. (Arstila et al. 2007, 2008). Because of this, glass composi-
tion of commercial BonAlive® S53P4 was adjusted, first of all, by addition of B2O3, but 
especially with introduction of MgO in some of the investigated glasses. In general, alkali 
earth metals have been found to increase the working range for hot forming applications. 
(Brink 1997).  
DTA results for the fine glass particles are presented on Fig. 13. These results show the 
effect of increasing MgO content on both Tg and Tx values of the investigated glasses. As 
a result of decreased Tg, the working range ∆T was observed to increase from approxi-
mately 30 to 50 °C with 5 to 10 mol% substitution, respectively. The impact was not as 
self-explanatory with the coarse particles, however similar trend could be observed. Sur-
prisingly, also glass composition with 10 mol% Sr introduction expressed relatively pref-
erable properties. This results were in agreement with study of Massera & Hupa 2014, 
where it was found that when molar content of SrO in glass exceeding 5 mol%, the crys-
tallization rate and peak intensity decreased, yet however during this study, this did not 
cause decrease in the working range (table 7 and 8). Results acquired with DTA indicated 
two different Tg´s for glass containing both Mg and Sr. This could be attributed to phase 
separation; an uneven distribution of forming ions within the structure. (Moynihan et al. 
1971). As expected, DTA traces exhibit a shift towards higher crystallization tempera-
tures for the coarse glass particles (Chatzistavrou et al. 2006; Massera et al. 2012a). This 
is typically expected as larger particles tend to exhibit a thermal lag compared to fine 
particles (Rabinovitch 1985). 
During the sintering, it was found out that in tested conditions, the glasses of larger par-
ticle size did not sinter properly. With DTA, coarse glass of B12.5 was determined to 
have hot forming domain of approximately 160 °C. When sintered within this temperature 
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range, inspected glass B12.5 did not form to a solid specimen. Not only the sintering did 
not lead to a solid samples but crystallization started already in temperature 60 °C below 
Tx. Similar phenomenon was observed with other inspected compositions of the larger 
particle size. Therefore it appears that these glasses were not as promising for sintering 
when using large particles. 
Sintering of finer glass particles was more successful, indicating that problems of the 
coarse glass particles could possibly be attributable to the non-uniformity and relatively 
large size distribution observed (Fig. 8). In general, uniformity in particle size is more 
favourable for sintering. (Rabinovich 1985). Additionally, result can be attributed to more 
rapid sintering of fine particles with annihilation of the significant part of the surface 
before the onset of crystallization. (Arstila et al. 2008; Chatzistavrou et al. 2006). Never-
theless, the glass B12.5 shows limited sinterability as seen in the SEM images (Fig. 14A). 
Especially the SEM images of the fine glass B12.5 shows low sinterability and initial 
crystallization at Tx-40 °C. Such behavior was expected from the study of Ojha (Ojha 
2016). Addition of Mg seem to improve greatly the sinterability of the glass. Indeed, SEM 
images (Fig. 14C and 14E) shows almost fully sintered body with very limited residual 
porosity and air bubbles. Despite the XRD diffractogram showing initial crystallization 
at Tx-40 °C, the crystallinity of the material seems to be relatively low. Crystallite can be 
observed as bright spherical shapes in the SEM images. The small extent of crystallization 
along with the really high viscous flow of the glass particles could lead to assume, that 
sintering, prior to glass crystallization, could be achieved at lower temperature. A slightly 
lower sintering temperature could lead to a partially sintered body, with some porosity 
and without crystallite. This is even further supported by the low intensity of the crystal-
lization peaks at the studied sintering temperature (Fig. 18-19). 
Glass containing increasing amount (10 mol%) of Sr (Fig. 15C) also expressed better 
sinterability than the based glass B12.5. Sintering was however not as good as the ones 
observed in Mg containing glasses. Similarly to the other glasses, the XRD pattern sug-
gest crystallization already at Tx-40 °C (Fig. 20 and 21). Based on the results, it appears 
that both Sr and Mg tend to shift the viscosity curve to lower temperatures as expected 
from (Massera & Hupa 2014) and (Massera et al. 2012b). 
Mixture composition of B12.5-Mg5-Sr10 was perhaps the most interesting, as the com-
position seemed to sinter relatively well (Fig. 15E) while remaining amorphous (Fig. 22). 
In addition, there is a hypothesis that phase separation may be important for controlling 
or preventing crystallization. This depends likely from multiple factors, including the 
composition, network and its connectivity, phosphate content, modifiers and initial glass 
treatment. (Brauer 2015). Phase separation was suspected from the SDTA analysis and 
was confirmed with the contrast change within particles cross section seen in Fig. 15E, 
indicating two distinct glass composition.  
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Crystallization, in most cases, starts from the surface of the glass, and should be greater 
in the case of a higher surface area. Also, defects caused by crushing of glass can act as 
nucleation points where crystallization may occur. (Arstila et al. 2008.) The crystalliza-
tion on the possible grain boundaries observed with SEM in Mg containing glasses could 
suggest that crystallization of these composition starts from the materials surface. This 
could be further studied analysing for example if intensity of the crystal peaks is affected 
by surface-to-volume ratio of the inspected glass specimen. (Massera et al. 2012a). Nev-
ertheless, more detailed crystallization study is needed to confirm glass crystallization 
kinetics and dimensionality.  
6.3 Dissolution and bioactivity 
Dissolution of ions is one the most important characteristic when selecting bioactive 
glasses for different applications (Hupa et al. 2016). In this study, dissolution was ana-
lyzed by the means of pH measurements, ICP-OES for the dissolution solution SBF, and 
FTIR for the immersed glass specimen. 
It is well known that the surface apatite layer of glass is formed by a chemical reaction of 
the material with the ions in the body fluid. SBF is a solution which has the ion concen-
tration and pH almost equal to human blood plasma. However, when performing in vitro 
dissolution studies the conditions used and the simulated body ﬂuid solution do not com-
pletely match those of a human body. (Brauer 2015; Macon et al. 2015). As a dissolution 
solution, SBF is highly supersaturated toward apatite formation; therefore, dissolution in 
this medium usually results in relatively quick precipitation of HA (Kokubo et al. 1990).  
As seen in Fig. 23 and 24, the pH of all immersion solutions increased with increasing 
the immersion time. These changes are typical in in vitro dissolution of both silicate and 
borate bioactive glass compositions (George 2015; Varila et al. 2012). Increase in pH 
indicates more free ions in dissolution solution, which can be attributed to release of ions 
from the dissolving glass. Typically, an increase in pH is due to the release of large 
amount of alkali and alkaline earth ions. Change in pH was observed to be faster for finer 
particle size glasses than for the coarse ones (Fig. 23 and 24). This is due to the higher 
surface area of fine glass particles opposed to the coarse one. This, in turn, leads to more 
atoms in contact with the surrounding solution and likely to be leached out of the network 
into the solutions.  
It is important to note that the surface area between the compared glass compositions was 
kept at relatively fixed ratio for the compared glass compositions, in order to maintain the 
amount of glass surface in contact with the solution. The surface area as an attribute is 
highly important, as maintaining it constant will allow to mimic a critical size defect filled 
with similar amount of glass. Only by maintaining the surface area constant, the changes 
in dissolution kinetics can be discussed as a function of composition. (Macon et al. 2015). 
This is also one aspect that has to be noted when designing scaffold structures; overall 
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surface area of the devices is affected by the porosity and how well the structure has been 
formed.  
From Fig. 24, showing the pH of the SBF as a function of immersion time for all glasses 
of investigation with fine particles size, it can be noted that all glasses containing Mg 
and/or Sr ions seemed to initially dissolve faster, however at longer immersion times the 
pH saturates, indicating the dissolution reaction is slowing down. The base B12.5 glass 
of the study was found to still have a sustain pH increase even at 168h of immersion, 
indicating that reaction is still proceeding. Although these particles were noted to be 
slightly bigger than rest of the fine particles (Fig.10), however the fast reaction of fine 
particles in SBF is often difficult to fully interpret due to fast reaction. Fig. 23 shows 
similar figure obtained for immersion of coarse particles. As compared to pH obtained 
for fine particles, the increase in pH is more sustained over the two weeks of immersion. 
The glasses containing 5 mol% of Mg and Sr do not seem to exhibit significant differences 
compared to the B12.5 glass. However, glass with 10 mol% of Mg and even more so, for 
the glass with 10 mol% of Sr and the mixture glass B12.5-Mg5-Sr10, the pH increase is 
reduced compared to the base glass. 
The pH of the solution should be related to the ion concentration in the solution, in this 
case the release of Si, B, Ca, P, Sr and Mg. The leaching of Si to the solution does not 
seem to be greatly affected by the glass composition. Only the glasses with 10 mol% SrO 
and the mixture glass seem to have slightly lower Si release. This is in agreement with 
Raman spectroscopy which indicated a larger number of Q3 units in the silica glass struc-
ture, less prone to be hydrolyzed. (Hill & Brauer 2011). The boron release was found be 
decrease with 10 mol% MgO and decreased even further for the glass containing 10 mol% 
SrO and the mixture glass. This is interesting as it could be interpreted that the introduc-
tion of Mg and Sr in large amounts at the expense of Ca stabilizes the boron network in 
the glasses. This is in agreement with the structural properties discussed which indicated 
increased stability of the boron groups in the glass system. 
The release of Ca ion is more challenging to interpret. Typically, in the case of bioactive 
glasses the Ca concentration in SBF first increases, and afterwards either remains constant 
or decreases. Such behavior is seen in parallel of a decrease of the P ion concentration 
with respect to time of immersion. This behavior can be related to precipitation of Ca-P 
on surface of the material. In case of bioactive glasses, this usually indicates formation of 
HA. (Massera & Hupa 2014). Here, the glass containing more Ca, as expected, release 
more Ca within the solution, whereas with glasses containing less Ca, namely B12.5-
Mg10, B12.5-Sr10 and the mixture glass, the Ca ion concentration did not seem to in-
crease during the immersion period (Fig. 27). Nonetheless, it can be noticed that the P 
concentration decreases in all of the solutions (Fig. 28). However, at 2 weeks of immer-
sion, it is clearly seen that an increase in Mg and Sr in the glass composition lead to a 
decrease in P consumption. The mixture glass exhibited lowest P consumption from all 
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of the investigated glasses. As the decrease in the P content can be related to HA precip-
itation, it can be assumed that large (in this case, 10 mol%) substitution of Ca in the 
studied borosilicate glass composition slows down the precipitation of HA. This would 
be in line with the lower pH increase (Fig. 23) indicating a slower dissolution rate due to 
stabilization of the borate and silicate sub network.  
As expected the Mg and Sr release (Fig. 29 and 30) shows release of these cations within 
the solution. With coarse particles, the initial dissolution rate of Sr seemed to be faster 
than one of Mg, and somewhat slower in the mixture composition, however results with 
fine particle size (not presented) indicated, that eventually the release saturates to be in 
consistency of the content of Mg and Sr in the glasses.  
Changes in the FTIR spectra suggest disappearance of silicate and borate bonds (band at 
~950 cm-1 range in Fig. 9), at the expanse of the band at ~1100 cm-1, attributed to phos-
phate, which gets stronger. Overall, this indicates that the glass backbone is breaking 
down, and a reactive phosphate layer forms at the surface of the glasses as seen in  previ-
ous studies (Massera & Hupa 2014; Massera et al. 2012b) (Fig. 31 & 32). At longer im-
mersion times, it can be observed than small addition of Mg and Sr improve the assumed 
Ca-P formation (Fig. 33), whereas larger concentrations reduce the reaction rate. This has 
also been noted in studies by Massera et al. (Massera et al. 2012b; Massera & Hupa 2014).  
It is conceivable that Mg and Sr doped glasses could lead to Mg and Sr doped HA, which 
may have different precipitation rate and stability. This might be indicated by broader 
phosphate related peak in Sr containing compositions (Fig.34). In previous study (Mass-
era & Hupa 2014), it was found that a minimum of 10 mol% of Sr was necessary to 
precipitate Sr substituted HA layer. Results suggested slower HA formation rate on the 
composition of mixture glass which contained both Mg and Sr. This could be due to either 
the phase separation, or precipitation of a Mg-Sr HA. Among other following analysis, 
this will be studied more in depth in the future.  
In conclusion, the formation of HA at the surface of all glass compositions indicates that 
the studied materials should be bioactive. The presence of large amount of Sr (10 mol%) 
leads to a decrease in glass reactivity, in turns leading to slower B release. This is bene-
ficial, as it was found in the other research performed in the group, that fast dissolving 
glasses are poor substrate to the cell adhesion and large B content within the media tend 
to decrease the cells activity (data not yet published). Furthermore, the release of Sr in 
the media as well as Sr in the HA layer was found to be beneficial to gingival fibroblasts 
cells viability and proliferation (Massera et al. 2015b). Therefore, the combination of Mg 
and Sr within the glass may reveal to be beneficial for bone applications.  
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7. CONCLUSIONS 
In this study, six novel borosilicate glass composition based on commercial S53P4 glass 
were produced, and characterized for their physical and structural properties. The prop-
erties of the borosilicate glass were modified by introduction of Mg and Sr, hoping to 
manufacture glasses with enhanced thermal and dissolution properties. 
In preliminary assessing of sintering behavior, notable differences in thermal properties 
and sinterability were observed between studied glass compositions. The particle size of 
the sintered glass had a notable effect, as sintering of coarse glass particles sieved to size 
of 250-500 µm did not work in the tested conditions. Good results were obtained, in the 
other hand, with fine particles with diameter smaller than 38 µm. Overall, introduction of 
Mg and Sr did seem to improve the properties. However, further analysis of sintered spec-
imen revealed crystallization in all of the glass compositions. Mg did seem to widen hot 
forming domain and sinterability, but as crystallization was observed, sintering in lower 
temperatures could be investigated in more detail. This is made possible as Mg seem to 
lower the viscosity of the glass. Sr seemed to have decreasing impact to the crystallization 
of the investigated compositions. While the mixture composition possessed quite narrow 
hot forming domain and phase separation within the structure, it proved to be perhaps the 
most interesting composition due to relatively good sinterability and low crystallization. 
Both sinterability and crystallization of the bioactive glass could relate directly to me-
chanical properties of sintered scaffold structures prepared from the material. Although 
in general crystallization is not desired, it should be noted that glasses showing higher 
tendency to crystallize have been shown to have higher in vitro bioactivity. (Arstila et al. 
2008). 
The possible bioactivity was assessed by dissolution of the glasses in SBF. Rapid HA 
formation was seen with all investigated specimen, indicating bioactivity of all studied 
glass compositions. Additionally, it was suspected that the introduced alkali earth metals 
resulted in Mg and Sr doped HA. Interestingly, it appears from structural investigation 
and deep analysis of in vitro dissolution test that substitution of large amount of Sr and 
Mg for Ca stabilize the borate network. Such stabilizing effect could be of tremendous 
interest to control the release of boron and maintain it at a level where it has a beneficial 
effect on bone formation. However, further testing is needed with in vitro cell tests to 
gain more insight about the effects of the glasses on cell proliferation and differentiation.  
Based on the results, the investigated borosilicate glass compositions seem promising for 
tissue engineering applications. Further testing in terms of both bioactivity and sintering 
and crystallization behavior is needed to assess if these bioactive glasses would be suita-
ble for example production of porous scaffold structures. Hence, the studies with the in-
vestigated glasses continue. 
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APPENDIX A: SIMULATED BODY FLUID 
 
1 liter of SBF solution was prepared by adding reagents to solution in the following order; 
 
Order Reagent mass (g) / volume 
1. NaCl 7.996  
2. NaHCO3  0.350  
3. KCl  0.224  
4. K2HPO4 · 3H2O  0.228  
5. MgCl2 · 6H2O  0.305  
6. 1M HCl (aq)  ~ 40 ml 
7. CaCl2 · 2H2O  0.368  
8. Na2SO4  0.071  
9. 2-Amino-2-(hydroxymethyl)-1,3-propane-
diol * 
6.057  
 * Tris base 
 
pH of the prepared solution was measured at +37 ±0.2°C and adjusted to pH 7.38-7.42 
with HCl. Solution was stored in +4 °C. 
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APPENDIX B: DTA CURVES 
 
Figure A. Plotted SDTA curves for coarse glass particles 
 
Figure B. Plotted DTA curves for fine glass particles 
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APPENDIX C: ICP-OES RESULTS  
 
 
1) B12.5 coarse particle size 
 
 
2) B12.5-Mg5 coarse particle size 
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3) B12.5-Mg10 coarse particle size 
 
 
4) B12.5-Sr5 coarse particle size 
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5) B12.5-Sr10 coarse particle size 
 
 
6) B12.5-Mg5-Sr10 coarse particle size 
Figure C. Ion release concentration (ppm) for elements B, Si, Ca, P, Mg, Sr as a 
function of immersion time. Elements determined for coarse glass particles of all 
studied glass compositions (1-6), for immersion in SBF up to 2 weeks. 
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1) B12.5 fine particle size 
 
 
 
2) B12.5-Mg5 fine particle size 
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3) B12.5-Mg10 fine particle size 
 
 
4) B12.5-Sr5 fine particle size 
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5) B12.5-Sr10 fine particle size 
 
 
6) B12.5-Mg5-Sr10 fine particle size 
Figure D. Ion release concentration (ppm) for elements B, Si, Ca, P, Mg, Sr as a 
function of immersion time. Elements determined for fine glass particles of all stud-
ied glass compositions (1-6), for immersion in SBF up to 1 week. 
 
